Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Randomiseret evaluering af langtids antikoagulerende terapi (RE-LY) med Dabigatran Etexilat

8. april 2019 opdateret af: Boehringer Ingelheim

Randomiseret evaluering af langtids antikoagulerende terapi (RE-LY) der sammenligner effektiviteten og sikkerheden af ​​to blindede doser af Dabigatran Etexilat med Open Label Warfarin til forebyggelse af slagtilfælde og systemisk emboli hos patienter med ikke-valvulær atrieflimren: Prospektiv, multicenter , Parallel-gruppe, Non-inferiority Trial (RE-LY-undersøgelse)

Det primære formål med dette forsøg er at demonstrere effektiviteten og sikkerheden af ​​dabigatran etexilat hos patienter med ikke-valvulær atrieflimren til forebyggelse af slagtilfælde og systemisk emboli.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

18113

Fase

  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Argentina
      • Bahía Blanca, Argentina
        • 1160.26.0523 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 1160.26.0524 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 1160.26.0533 Boehringer Ingelheim Investigational Site
      • Cipolletti, Argentina
        • 1160.26.0526 Boehringer Ingelheim Investigational Site
      • Coronel Suárez, Argentina
        • 1160.26.0529 Boehringer Ingelheim Investigational Site
      • Córdoba, Argentina
        • 1160.26.0531 Boehringer Ingelheim Investigational Site
      • La Plata, Argentina
        • 1160.26.0530 Boehringer Ingelheim Investigational Site
      • Mar del Plata, Argentina
        • 1160.26.0527 Boehringer Ingelheim Investigational Site
      • Mar del Plata, Argentina
        • 1160.26.0532 Boehringer Ingelheim Investigational Site
      • Quilmes, Argentina
        • 1160.26.0525 Boehringer Ingelheim Investigational Site
      • Rosario, Argentina
        • 1160.26.0521 Boehringer Ingelheim Investigational Site
      • Salta, Argentina
        • 1160.26.0528 Boehringer Ingelheim Investigational Site
      • Santa Fe, Argentina
        • 1160.26.0522 Boehringer Ingelheim Investigational Site
  • Australien
    • New South Wales
      • Coffs Harbour, New South Wales, Australien
        • 1160.26.0508 Boehringer Ingelheim Investigational Site
      • Gosford, New South Wales, Australien
        • 1160.26.0510 Boehringer Ingelheim Investigational Site
    • Queensland
      • Herston, Queensland, Australien
        • 1160.26.0505 Boehringer Ingelheim Investigational Site
      • Milton, Queensland, Australien
        • 1160.26.0506 Boehringer Ingelheim Investigational Site
    • South Australia
      • Ashford, South Australia, Australien
        • 1160.26.0509 Boehringer Ingelheim Investigational Site
    • Tasmania
      • Launceston, Tasmania, Australien
        • 1160.26.0507 Boehringer Ingelheim Investigational Site
    • Victoria
      • Box Hill, Victoria, Australien
        • 1160.26.0504 Boehringer Ingelheim Investigational Site
      • Geelong, Victoria, Australien
        • 1160.26.0501 Boehringer Ingelheim Investigational Site
      • Parkville, Victoria, Australien
        • 1160.26.0502 Boehringer Ingelheim Investigational Site
      • Prahran, Victoria, Australien
        • 1160.26.0503 Boehringer Ingelheim Investigational Site
  • Belgien
      • Aalst, Belgien
        • 1160.26.0564 Boehringer Ingelheim Investigational Site
      • Antwerpen, Belgien
        • 1160.26.0573 Boehringer Ingelheim Investigational Site
      • Antwerpen, Belgien
        • 1160.26.0575 Boehringer Ingelheim Investigational Site
      • Brasschaat, Belgien
        • 1160.26.0572 Boehringer Ingelheim Investigational Site
      • Brugge, Belgien
        • 1160.26.0577 Boehringer Ingelheim Investigational Site
      • Brussels, Belgien
        • 1160.26.0571 Boehringer Ingelheim Investigational Site
      • Bruxelles, Belgien
        • 1160.26.0581 Boehringer Ingelheim Investigational Site
      • Bruxelles, Belgien
        • 1160.26.0585 Boehringer Ingelheim Investigational Site
      • Bruxelles, Belgien
        • 1160.26.0586 Boehringer Ingelheim Investigational Site
      • Edegem, Belgien
        • 1160.26.0563 Boehringer Ingelheim Investigational Site
      • Genk, Belgien
        • 1160.26.0578 Boehringer Ingelheim Investigational Site
      • Genk, Belgien
        • 1160.26.0587 Boehringer Ingelheim Investigational Site
      • Gent, Belgien
        • 1160.26.0574 Boehringer Ingelheim Investigational Site
      • Gilly, Belgien
        • 1160.26.0588 Boehringer Ingelheim Investigational Site
      • Haine-St.-Paul, Belgien
        • 1160.26.0580 Boehringer Ingelheim Investigational Site
      • Hasselt, Belgien
        • 1160.26.0568 Boehringer Ingelheim Investigational Site
      • Kortrijk, Belgien
        • 1160.26.0569 Boehringer Ingelheim Investigational Site
      • Leuven, Belgien
        • 1160.26.0561 Boehringer Ingelheim Investigational Site
      • Liège, Belgien
        • 1160.26.0579 Boehringer Ingelheim Investigational Site
      • Liège, Belgien
        • 1160.26.0583 Boehringer Ingelheim Investigational Site
      • Mol, Belgien
        • 1160.26.0589 Boehringer Ingelheim Investigational Site
      • Oostende, Belgien
        • 1160.26.0567 Boehringer Ingelheim Investigational Site
      • Roeselare, Belgien
        • 1160.26.0570 Boehringer Ingelheim Investigational Site
      • Tienen, Belgien
        • 1160.26.0566 Boehringer Ingelheim Investigational Site
      • Turnhout, Belgien
        • 1160.26.0562 Boehringer Ingelheim Investigational Site
  • Brasilien
      • Belo Horizonte, Brasilien
        • 1160.26.550648 Boehringer Ingelheim Investigational Site
      • Blumenau, Brasilien
        • 1160.26.550654 Boehringer Ingelheim Investigational Site
      • Campinas, Brasilien
        • 1160.26.550644 Boehringer Ingelheim Investigational Site
      • Curitiba, Brasilien
        • 1160.26.550650 Boehringer Ingelheim Investigational Site
      • Curitiba, Brasilien
        • 1160.26.550651 Boehringer Ingelheim Investigational Site
      • Curitiba, Brasilien
        • 1160.26.550653 Boehringer Ingelheim Investigational Site
      • Goiania, Brasilien
        • 1160.26.550652 Boehringer Ingelheim Investigational Site
      • Marília, Brasilien
        • 1160.26.550645 Boehringer Ingelheim Investigational Site
      • São José do Rio Preto, Brasilien
        • 1160.26.550646 Boehringer Ingelheim Investigational Site
      • São José do Rio Preto, Brasilien
        • 1160.26.550647 Boehringer Ingelheim Investigational Site
      • São Paulo, Brasilien
        • 1160.26.550641 Boehringer Ingelheim Investigational Site
      • São Paulo, Brasilien
        • 1160.26.550642 Boehringer Ingelheim Investigational Site
      • São Paulo, Brasilien
        • 1160.26.550643 Boehringer Ingelheim Investigational Site
      • Uberaba, Brasilien
        • 1160.26.550649 Boehringer Ingelheim Investigational Site
  • Bulgarien
      • Pleven, Bulgarien
        • 1160.26.0620 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0611 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0612 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0613 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0614 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0615 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0616 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0617 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0618 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0622 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0623 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0624 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 1160.26.0625 Boehringer Ingelheim Investigational Site
      • Stara Zagora, Bulgarien
        • 1160.26.0626 Boehringer Ingelheim Investigational Site
      • Varna, Bulgarien
        • 1160.26.0621 Boehringer Ingelheim Investigational Site
  • Canada
    • Alberta
      • Calgary, Alberta, Canada
        • 1160.26.0694 Boehringer Ingelheim Investigational Site
      • Calgary, Alberta, Canada
        • 1160.26.0696 Boehringer Ingelheim Investigational Site
    • British Columbia
      • Coquitlam, British Columbia, Canada
        • 1160.26.0680 Boehringer Ingelheim Investigational Site
      • Coquitlam, British Columbia, Canada
        • 1160.26.0712 Boehringer Ingelheim Investigational Site
      • Kelowna, British Columbia, Canada
        • 1160.26.0706 Boehringer Ingelheim Investigational Site
      • Nanaimo, British Columbia, Canada
        • 1160.26.0725 Boehringer Ingelheim Investigational Site
      • New Westminster, British Columbia, Canada
        • 1160.26.0691 Boehringer Ingelheim Investigational Site
      • Victoria, British Columbia, Canada
        • 1160.26.0714 Boehringer Ingelheim Investigational Site
    • Manitoba
      • Portage la Prairie, Manitoba, Canada
        • 1160.26.0701 Boehringer Ingelheim Investigational Site
      • Winnipeg, Manitoba, Canada
        • 1160.26.0698 Boehringer Ingelheim Investigational Site
    • Newfoundland and Labrador
      • Bay Roberts, Newfoundland and Labrador, Canada
        • 1160.26.0707 Boehringer Ingelheim Investigational Site
    • Nova Scotia
      • Antigonish, Nova Scotia, Canada
        • 1160.26.0676 Boehringer Ingelheim Investigational Site
      • Halifax, Nova Scotia, Canada
        • 1160.26.0703 Boehringer Ingelheim Investigational Site
    • Ontario
      • Ajax, Ontario, Canada
        • 1160.26.0679 Boehringer Ingelheim Investigational Site
      • Brampton, Ontario, Canada
        • 1160.26.0677 Boehringer Ingelheim Investigational Site
      • Burlington, Ontario, Canada
        • 1160.26.0674 Boehringer Ingelheim Investigational Site
      • Cambridge, Ontario, Canada
        • 1160.26.0702 Boehringer Ingelheim Investigational Site
      • Cambridge, Ontario, Canada
        • 1160.26.0720 Boehringer Ingelheim Investigational Site
      • Etobicoke, Ontario, Canada
        • 1160.26.0671 Clinical Research & Diagnostic Solutions Inc.
      • Grimsby, Ontario, Canada
        • 1160.26.0692 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.26.0685 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.26.0697 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.26.0710 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.26.0719 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 1160.26.0721 Boehringer Ingelheim Investigational Site
      • Kitchener, Ontario, Canada
        • 1160.26.0689 Boehringer Ingelheim Investigational Site
      • Mississauga, Ontario, Canada
        • 1160.26.0695 Boehringer Ingelheim Investigational Site
      • Mississauga, Ontario, Canada
        • 1160.26.0708 Boehringer Ingelheim Investigational Site
      • Mississauga, Ontario, Canada
        • 1160.26.0724 Boehringer Ingelheim Investigational Site
      • Newmarket, Ontario, Canada
        • 1160.26.0688 Boehringer Ingelheim Investigational Site
      • Oshawa, Ontario, Canada
        • 1160.26.0672 Boehringer Ingelheim Investigational Site
      • Ottawa, Ontario, Canada
        • 1160.26.0687 Boehringer Ingelheim Investigational Site
      • Scarborough, Ontario, Canada
        • 1160.26.0723 Boehringer Ingelheim Investigational Site
      • Sudbury, Ontario, Canada
        • 1160.26.0715 Boehringer Ingelheim Investigational Site
      • Thunder Bay, Ontario, Canada
        • 1160.26.0690 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 1160.26.0684 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 1160.26.0718 Boehringer Ingelheim Investigational Site
      • Waterloo, Ontario, Canada
        • 1160.26.0711 Boehringer Ingelheim Investigational Site
      • Windsor, Ontario, Canada
        • 1160.26.0686 Boehringer Ingelheim Investigational Site
    • Quebec
      • Longueuil, Quebec, Canada
        • 1160.26.0693 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 1160.26.0681 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 1160.26.0683 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 1160.26.0705 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 1160.26.0709 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 1160.26.0716 Boehringer Ingelheim Investigational Site
      • Quebec City, Quebec, Canada
        • 1160.26.0717 Boehringer Ingelheim Investigational Site
      • Saint George-de-Beauce, Quebec, Canada
        • 1160.26.0713 Boehringer Ingelheim Investigational Site
      • Saint Jerome, Quebec, Canada
        • 1160.26.0704 Boehringer Ingelheim Investigational Site
      • St. Charles-Borromee, Quebec, Canada
        • 1160.26.0699 Boehringer Ingelheim Investigational Site
      • St. Hyacinthe, Quebec, Canada
        • 1160.26.0675 Boehringer Ingelheim Investigational Site
      • Ste-Foy, Quebec, Canada
        • 1160.26.0700 Boehringer Ingelheim Investigational Site
      • Terrebonne (Lachenaie), Quebec, Canada
        • 1160.26.0682 Boehringer Ingelheim Investigational Site
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada
        • 1160.26.0673 Boehringer Ingelheim Investigational Site
      • Saskatoon, Saskatchewan, Canada
        • 1160.26.0678 Boehringer Ingelheim Investigational Site
  • Colombia
      • Bogotá, Colombia
        • 1160.26.0801 Boehringer Ingelheim Investigational Site
      • Bogotá, Colombia
        • 1160.26.0802 Boehringer Ingelheim Investigational Site
      • Bogotá, Colombia
        • 1160.26.0803 Boehringer Ingelheim Investigational Site
  • Danmark
      • Aalborg, Danmark
        • 1160.26.0837 Boehringer Ingelheim Investigational Site
      • Aarhus C, Danmark
        • 1160.26.0835 Boehringer Ingelheim Investigational Site
      • Frederikssund, Danmark
        • 1160.26.0838 Boehringer Ingelheim Investigational Site
      • Helsingør, Danmark
        • 1160.26.0833 Boehringer Ingelheim Investigational Site
      • Herlev, Danmark
        • 1160.26.0834 Boehringer Ingelheim Investigational Site
      • Horsens, Danmark
        • 1160.26.0841 Boehringer Ingelheim Investigational Site
      • Hvidovre, Danmark
        • 1160.26.0832 Boehringer Ingelheim Investigational Site
      • Køge, Danmark
        • 1160.26.0840 Boehringer Ingelheim Investigational Site
      • Odense, Danmark
        • 1160.26.0831 Boehringer Ingelheim Investigational Site
      • Roskilde, Danmark
        • 1160.26.0839 Boehringer Ingelheim Investigational Site
      • Svendborg, Danmark
        • 1160.26.0836 Boehringer Ingelheim Investigational Site
  • Den Russiske Føderation
      • Moscow, Den Russiske Føderation
        • 1160.26.1501 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1502 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1503 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1504 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1505 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1506 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1507 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1508 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1509 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1510 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 1160.26.1511 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 1160.26.1512 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 1160.26.1513 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 1160.26.1514 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 1160.26.1515 Boehringer Ingelheim Investigational Site
  • Det Forenede Kongerige
      • Birmingham, Det Forenede Kongerige
        • 1160.26.1744 Boehringer Ingelheim Investigational Site
      • Chertsey, Det Forenede Kongerige
        • 1160.26.1746 Boehringer Ingelheim Investigational Site
      • Glasgow, Det Forenede Kongerige
        • 1160.26.1747 Boehringer Ingelheim Investigational Site
      • Harrow, Det Forenede Kongerige
        • 1160.26.1750 Boehringer Ingelheim Investigational Site
      • Hull, Det Forenede Kongerige
        • 1160.26.1753 Boehringer Ingelheim Investigational Site
      • Kirkcaldy, Fife, Det Forenede Kongerige
        • 1160.26.1755 Boehringer Ingelheim Investigational Site
      • London, Det Forenede Kongerige
        • 1160.26.1741 Boehringer Ingelheim Investigational Site
      • London, Det Forenede Kongerige
        • 1160.26.1756 Boehringer Ingelheim Investigational Site
      • Londonderry, Det Forenede Kongerige
        • 1160.26.1749 Boehringer Ingelheim Investigational Site
      • Newcastle upon Tyne, Det Forenede Kongerige
        • 1160.26.1742 Boehringer Ingelheim Investigational Site
      • Newport, Det Forenede Kongerige
        • 1160.26.1751 Boehringer Ingelheim Investigational Site
      • Northampton, Det Forenede Kongerige
        • 1160.26.1752 Boehringer Ingelheim Investigational Site
      • Portadown, County Atrim, Det Forenede Kongerige
        • 1160.26.1745 Boehringer Ingelheim Investigational Site
      • Romford, Essex, Det Forenede Kongerige
        • 1160.26.1743 Boehringer Ingelheim Investigational Site
      • Stoke-On-Trent, Det Forenede Kongerige
        • 1160.26.1754 Boehringer Ingelheim Investigational Site
      • York, Det Forenede Kongerige
        • 1160.26.1748 Boehringer Ingelheim Investigational Site
  • Filippinerne
      • Manila, Filippinerne
        • 1160.26.1421 Philippine General Hospital
      • Manila, Filippinerne
        • 1160.26.1422 Manila Doctors Hospital
      • Pasig City, Filippinerne
        • 1160.26.1424 The Medical City
      • Quezon City, Filippinerne
        • 1160.26.1423 Philippine Heart Center
      • Quezon City, Filippinerne
        • 1160.26.1425 St Lukes Medical Center
  • Finland
      • Espoo, Finland
        • 1160.26.0856 Boehringer Ingelheim Investigational Site
      • HUS, Finland
        • 1160.26.0851 Boehringer Ingelheim Investigational Site
      • Jyväskylä, Finland
        • 1160.26.0859 Boehringer Ingelheim Investigational Site
      • Kuopio, Finland
        • 1160.26.0855 Boehringer Ingelheim Investigational Site
      • Lappeenranta, Finland
        • 1160.26.0857 Boehringer Ingelheim Investigational Site
      • OYS, Finland
        • 1160.26.0854 Boehringer Ingelheim Investigational Site
      • Pori, Finland
        • 1160.26.0858 Boehringer Ingelheim Investigational Site
      • Tampere, Finland
        • 1160.26.0852 Boehringer Ingelheim Investigational Site
      • Turku, Finland
        • 1160.26.0853 Boehringer Ingelheim Investigational Site
  • Forenede Stater
    • Alabama
      • Birmingham, Alabama, Forenede Stater
        • 1160.26.0009 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 1160.26.0046 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 1160.26.0057 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 1160.26.0211 Boehringer Ingelheim Investigational Site
      • Huntsville, Alabama, Forenede Stater
        • 1160.26.0206 Boehringer Ingelheim Investigational Site
      • Mobile, Alabama, Forenede Stater
        • 1160.26.0115 Boehringer Ingelheim Investigational Site
    • Arizona
      • Lake Havasu City, Arizona, Forenede Stater
        • 1160.26.0104 Boehringer Ingelheim Investigational Site
      • Peoria, Arizona, Forenede Stater
        • 1160.26.0304 Boehringer Ingelheim Investigational Site
      • Tucson, Arizona, Forenede Stater
        • 1160.26.0185 Boehringer Ingelheim Investigational Site
      • Tucson, Arizona, Forenede Stater
        • 1160.26.0305 Boehringer Ingelheim Investigational Site
    • Arkansas
      • Hot Springs, Arkansas, Forenede Stater
        • 1160.26.0038 Boehringer Ingelheim Investigational Site
      • Jonesboro, Arkansas, Forenede Stater
        • 1160.26.0302 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Forenede Stater
        • 1160.26.0121 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Forenede Stater
        • 1160.26.0191 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Forenede Stater
        • 1160.26.0204 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Forenede Stater
        • 1160.26.0213 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Forenede Stater
        • 1160.26.0455 Boehringer Ingelheim Investigational Site
    • California
      • Anaheim, California, Forenede Stater
        • 1160.26.0388 Boehringer Ingelheim Investigational Site
      • Carmichael, California, Forenede Stater
        • 1160.26.0441 Boehringer Ingelheim Investigational Site
      • French Camp, California, Forenede Stater
        • 1160.26.0145 Boehringer Ingelheim Investigational Site
      • Fullerton, California, Forenede Stater
        • 1160.26.0333 Boehringer Ingelheim Investigational Site
      • La Jolla, California, Forenede Stater
        • 1160.26.0384 Boehringer Ingelheim Investigational Site
      • La Mesa, California, Forenede Stater
        • 1160.26.0091 Boehringer Ingelheim Investigational Site
      • Lancaster, California, Forenede Stater
        • 1160.26.0246 Boehringer Ingelheim Investigational Site
      • Larkspur, California, Forenede Stater
        • 1160.26.0345 Boehringer Ingelheim Investigational Site
      • Loma Linda, California, Forenede Stater
        • 1160.26.0217 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 1160.26.0059 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 1160.26.0088 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 1160.26.0337 Boehringer Ingelheim Investigational Site
      • Mather, California, Forenede Stater
        • 1160.26.0326 Boehringer Ingelheim Investigational Site
      • Merced, California, Forenede Stater
        • 1160.26.0070 Boehringer Ingelheim Investigational Site
      • Oakland, California, Forenede Stater
        • 1160.26.0349 Boehringer Ingelheim Investigational Site
      • Oceanside, California, Forenede Stater
        • 1160.26.0016 Boehringer Ingelheim Investigational Site
      • Palm Springs, California, Forenede Stater
        • 1160.26.0087 Boehringer Ingelheim Investigational Site
      • Pasadena, California, Forenede Stater
        • 1160.26.0459 Boehringer Ingelheim Investigational Site
      • Redondo Beach, California, Forenede Stater
        • 1160.26.0216 Boehringer Ingelheim Investigational Site
      • Riverside, California, Forenede Stater
        • 1160.26.0135 Boehringer Ingelheim Investigational Site
      • Sacramento, California, Forenede Stater
        • 1160.26.0162 Boehringer Ingelheim Investigational Site
      • Sacramento, California, Forenede Stater
        • 1160.26.0300 Boehringer Ingelheim Investigational Site
      • Sacramento, California, Forenede Stater
        • 1160.26.0371 Boehringer Ingelheim Investigational Site
      • San Diego, California, Forenede Stater
        • 1160.26.0116 Boehringer Ingelheim Investigational Site
      • San Diego, California, Forenede Stater
        • 1160.26.0148 Boehringer Ingelheim Investigational Site
      • San Diego, California, Forenede Stater
        • 1160.26.0270 Boehringer Ingelheim Investigational Site
      • San Diego, California, Forenede Stater
        • 1160.26.0284 Boehringer Ingelheim Investigational Site
      • Santa Ana, California, Forenede Stater
        • 1160.26.0351 Boehringer Ingelheim Investigational Site
      • Santa Rosa, California, Forenede Stater
        • 1160.26.0043 Boehringer Ingelheim Investigational Site
      • Sylmar, California, Forenede Stater
        • 1160.26.0462 Boehringer Ingelheim Investigational Site
      • Torrance, California, Forenede Stater
        • 1160.26.0276 Boehringer Ingelheim Investigational Site
      • Walnut Creek, California, Forenede Stater
        • 1160.26.0379 Boehringer Ingelheim Investigational Site
    • Colorado
      • Aurora, Colorado, Forenede Stater
        • 1160.26.0419 Boehringer Ingelheim Investigational Site
      • Colorado Springs, Colorado, Forenede Stater
        • 1160.26.0321 Boehringer Ingelheim Investigational Site
      • Colorado Springs, Colorado, Forenede Stater
        • 1160.26.0449 Boehringer Ingelheim Investigational Site
      • Denver, Colorado, Forenede Stater
        • 1160.26.0360 Boehringer Ingelheim Investigational Site
      • Denver, Colorado, Forenede Stater
        • 1160.26.0413 Boehringer Ingelheim Investigational Site
      • Fort Collins, Colorado, Forenede Stater
        • 1160.26.0362 Boehringer Ingelheim Investigational Site
      • Greeley, Colorado, Forenede Stater
        • 1160.26.0399 Boehringer Ingelheim Investigational Site
    • Connecticut
      • Bridgeport, Connecticut, Forenede Stater
        • 1160.26.0058 Boehringer Ingelheim Investigational Site
      • Bridgeport, Connecticut, Forenede Stater
        • 1160.26.0241 Boehringer Ingelheim Investigational Site
      • Bridgeport, Connecticut, Forenede Stater
        • 1160.26.0278 Boehringer Ingelheim Investigational Site
      • Fairfield, Connecticut, Forenede Stater
        • 1160.26.0085 Boehringer Ingelheim Investigational Site
      • Guilford, Connecticut, Forenede Stater
        • 1160.26.0482 Boehringer Ingelheim Investigational Site
    • Delaware
      • Newark, Delaware, Forenede Stater
        • 1160.26.0366 Boehringer Ingelheim Investigational Site
    • District of Columbia
      • Washington, District of Columbia, Forenede Stater
        • 1160.26.0343 Boehringer Ingelheim Investigational Site
    • Florida
      • Atlantis, Florida, Forenede Stater
        • 1160.26.0022 Boehringer Ingelheim Investigational Site
      • Boynton Beach, Florida, Forenede Stater
        • 1160.26.0382 Boehringer Ingelheim Investigational Site
      • Brandon, Florida, Forenede Stater
        • 1160.26.0056 Boehringer Ingelheim Investigational Site
      • Clearwater, Florida, Forenede Stater
        • 1160.26.0105 Boehringer Ingelheim Investigational Site
      • Clearwater, Florida, Forenede Stater
        • 1160.26.0296 Boehringer Ingelheim Investigational Site
      • Clearwater, Florida, Forenede Stater
        • 1160.26.0429 Boehringer Ingelheim Investigational Site
      • Daytona Beach, Florida, Forenede Stater
        • 1160.26.0376 Boehringer Ingelheim Investigational Site
      • Deerfield Beach, Florida, Forenede Stater
        • 1160.26.0411 Boehringer Ingelheim Investigational Site
      • Fort Myers, Florida, Forenede Stater
        • 1160.26.0074 Boehringer Ingelheim Investigational Site
      • Gainesville, Florida, Forenede Stater
        • 1160.26.0239 Boehringer Ingelheim Investigational Site
      • Hollywood, Florida, Forenede Stater
        • 1160.26.0260 Boehringer Ingelheim Investigational Site
      • Hollywood, Florida, Forenede Stater
        • 1160.26.0265 Boehringer Ingelheim Investigational Site
      • Inverness, Florida, Forenede Stater
        • 1160.26.0100 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 1160.26.0033 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 1160.26.0089 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 1160.26.0232 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 1160.26.0240 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 1160.26.0427 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 1160.26.0464 Boehringer Ingelheim Investigational Site
      • Jacksonville Beach, Florida, Forenede Stater
        • 1160.26.0209 Boehringer Ingelheim Investigational Site
      • Lakeland, Florida, Forenede Stater
        • 1160.26.0012 Boehringer Ingelheim Investigational Site
      • Melbourne, Florida, Forenede Stater
        • 1160.26.0259 Boehringer Ingelheim Investigational Site
      • Melbourne, Florida, Forenede Stater
        • 1160.26.0358 Boehringer Ingelheim Investigational Site
      • Miami, Florida, Forenede Stater
        • 1160.26.0034 Boehringer Ingelheim Investigational Site
      • Miami, Florida, Forenede Stater
        • 1160.26.0199 Boehringer Ingelheim Investigational Site
      • Orlando, Florida, Forenede Stater
        • 1160.26.0227 Boehringer Ingelheim Investigational Site
      • Ormond Beach, Florida, Forenede Stater
        • 1160.26.0095 Boehringer Ingelheim Investigational Site
      • Pensacola, Florida, Forenede Stater
        • 1160.26.0037 Boehringer Ingelheim Investigational Site
      • Pensacola, Florida, Forenede Stater
        • 1160.26.0076 Boehringer Ingelheim Investigational Site
      • Pensacola, Florida, Forenede Stater
        • 1160.26.0081 Boehringer Ingelheim Investigational Site
      • Pensacola, Florida, Forenede Stater
        • 1160.26.0111 Boehringer Ingelheim Investigational Site
      • Port Charlotte, Florida, Forenede Stater
        • 1160.26.0137 Boehringer Ingelheim Investigational Site
      • Port Charlotte, Florida, Forenede Stater
        • 1160.26.0389 Boehringer Ingelheim Investigational Site
      • Port Charlotte, Florida, Forenede Stater
        • 1160.26.0417 Boehringer Ingelheim Investigational Site
      • Rockledge, Florida, Forenede Stater
        • 1160.26.0332 Boehringer Ingelheim Investigational Site
      • Safety Harbor, Florida, Forenede Stater
        • 1160.26.0226 Boehringer Ingelheim Investigational Site
      • Saint Petersburg, Florida, Forenede Stater
        • 1160.26.0015 Boehringer Ingelheim Investigational Site
      • Saint Petersburg, Florida, Forenede Stater
        • 1160.26.0339 Boehringer Ingelheim Investigational Site
      • Sarasota, Florida, Forenede Stater
        • 1160.26.0031 Boehringer Ingelheim Investigational Site
      • Sarasota, Florida, Forenede Stater
        • 1160.26.0385 Boehringer Ingelheim Investigational Site
      • Stuart, Florida, Forenede Stater
        • 1160.26.0010 Boehringer Ingelheim Investigational Site
      • Tamarac, Florida, Forenede Stater
        • 1160.26.0327 Boehringer Ingelheim Investigational Site
      • Tampa, Florida, Forenede Stater
        • 1160.26.0271 Boehringer Ingelheim Investigational Site
      • Tampa, Florida, Forenede Stater
        • 1160.26.0328 Boehringer Ingelheim Investigational Site
      • Tampa, Florida, Forenede Stater
        • 1160.26.0381 Boehringer Ingelheim Investigational Site
      • Vero Beach, Florida, Forenede Stater
        • 1160.26.0019 Boehringer Ingelheim Investigational Site
    • Georgia
      • Atlanta, Georgia, Forenede Stater
        • 1160.26.0159 Boehringer Ingelheim Investigational Site
      • Atlanta, Georgia, Forenede Stater
        • 1160.26.0283 Boehringer Ingelheim Investigational Site
      • Atlanta, Georgia, Forenede Stater
        • 1160.26.0338 Boehringer Ingelheim Investigational Site
      • Augusta, Georgia, Forenede Stater
        • 1160.26.0021 Boehringer Ingelheim Investigational Site
      • Augusta, Georgia, Forenede Stater
        • 1160.26.0319 Boehringer Ingelheim Investigational Site
      • Blue Ridge, Georgia, Forenede Stater
        • 1160.26.0092 Boehringer Ingelheim Investigational Site
      • Conyers, Georgia, Forenede Stater
        • 1160.26.0161 Boehringer Ingelheim Investigational Site
    • Idaho
      • Coeur d'Alene, Idaho, Forenede Stater
        • 1160.26.0026 Boehringer Ingelheim Investigational Site
    • Illinois
      • Berwyn, Illinois, Forenede Stater
        • 1160.26.0218 Boehringer Ingelheim Investigational Site
      • Chicago, Illinois, Forenede Stater
        • 1160.26.0184 Boehringer Ingelheim Investigational Site
      • Chicago, Illinois, Forenede Stater
        • 1160.26.0233 Boehringer Ingelheim Investigational Site
      • Chicago, Illinois, Forenede Stater
        • 1160.26.0324 Boehringer Ingelheim Investigational Site
      • Chicago, Illinois, Forenede Stater
        • 1160.26.0457 Boehringer Ingelheim Investigational Site
      • Evanston, Illinois, Forenede Stater
        • 1160.26.0237 Boehringer Ingelheim Investigational Site
      • Glenview, Illinois, Forenede Stater
        • 1160.26.0236 Boehringer Ingelheim Investigational Site
      • Hines, Illinois, Forenede Stater
        • 1160.26.0396 Boehringer Ingelheim Investigational Site
      • Maywood, Illinois, Forenede Stater
        • 1160.26.0438 Boehringer Ingelheim Investigational Site
      • Melrose Park, Illinois, Forenede Stater
        • 1160.26.0331 Boehringer Ingelheim Investigational Site
      • Normal, Illinois, Forenede Stater
        • 1160.26.0364 Boehringer Ingelheim Investigational Site
      • North Chicago, Illinois, Forenede Stater
        • 1160.26.0109 Boehringer Ingelheim Investigational Site
      • Oak Lawn, Illinois, Forenede Stater
        • 1160.26.0152 Boehringer Ingelheim Investigational Site
      • Rockford, Illinois, Forenede Stater
        • 1160.26.0198 Boehringer Ingelheim Investigational Site
      • Winfield, Illinois, Forenede Stater
        • 1160.26.0433 Boehringer Ingelheim Investigational Site
    • Indiana
      • Evansville, Indiana, Forenede Stater
        • 1160.26.0041 Boehringer Ingelheim Investigational Site
      • Fort Wayne, Indiana, Forenede Stater
        • 1160.26.0377 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Forenede Stater
        • 1160.26.0288 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Forenede Stater
        • 1160.26.0352 Boehringer Ingelheim Investigational Site
      • Indianapolis, Indiana, Forenede Stater
        • 1160.26.0436 Boehringer Ingelheim Investigational Site
      • Jeffersonville, Indiana, Forenede Stater
        • 1160.26.0028 Boehringer Ingelheim Investigational Site
      • South Bend, Indiana, Forenede Stater
        • 1160.26.0235 Boehringer Ingelheim Investigational Site
    • Iowa
      • Dubuque, Iowa, Forenede Stater
        • 1160.26.0268 Boehringer Ingelheim Investigational Site
      • West Des Moines, Iowa, Forenede Stater
        • 1160.26.0001 Boehringer Ingelheim Investigational Site
      • West Des Moines, Iowa, Forenede Stater
        • 1160.26.0189 Boehringer Ingelheim Investigational Site
      • West Des Moines, Iowa, Forenede Stater
        • 1160.26.0357 Boehringer Ingelheim Investigational Site
    • Kansas
      • Wichita, Kansas, Forenede Stater
        • 1160.26.0354 Boehringer Ingelheim Investigational Site
    • Kentucky
      • Bowling Green, Kentucky, Forenede Stater
        • 1160.26.0077 Boehringer Ingelheim Investigational Site
      • Crestview Hills, Kentucky, Forenede Stater
        • 1160.26.0138 Boehringer Ingelheim Investigational Site
      • Lexington, Kentucky, Forenede Stater
        • 1160.26.0422 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Forenede Stater
        • 1160.26.0178 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Forenede Stater
        • 1160.26.0397 Boehringer Ingelheim Investigational Site
      • Owensboro, Kentucky, Forenede Stater
        • 1160.26.0310 Boehringer Ingelheim Investigational Site
    • Louisiana
      • Baton Rouge, Louisiana, Forenede Stater
        • 1160.26.0011 Boehringer Ingelheim Investigational Site
      • Baton Rouge, Louisiana, Forenede Stater
        • 1160.26.0144 Boehringer Ingelheim Investigational Site
      • Baton Rouge, Louisiana, Forenede Stater
        • 1160.26.0404 Boehringer Ingelheim Investigational Site
      • Covington, Louisiana, Forenede Stater
        • 1160.26.0093 Boehringer Ingelheim Investigational Site
      • Lacombe, Louisiana, Forenede Stater
        • 1160.26.0340 Boehringer Ingelheim Investigational Site
      • Lafayette, Louisiana, Forenede Stater
        • 1160.26.0018 Boehringer Ingelheim Investigational Site
      • Lafayette, Louisiana, Forenede Stater
        • 1160.26.0391 Boehringer Ingelheim Investigational Site
      • Morgan City, Louisiana, Forenede Stater
        • 1160.26.0252 Boehringer Ingelheim Investigational Site
      • New Iberia, Louisiana, Forenede Stater
        • 1160.26.0132 Boehringer Ingelheim Investigational Site
      • New Orleans, Louisiana, Forenede Stater
        • 1160.26.0299 Tulane University School Of Medicine
      • Shreveport, Louisiana, Forenede Stater
        • 1160.26.0048 Boehringer Ingelheim Investigational Site
    • Maine
      • Auburn, Maine, Forenede Stater
        • 1160.26.0096 Boehringer Ingelheim Investigational Site
      • Scarborough, Maine, Forenede Stater
        • 1160.26.0068 Boehringer Ingelheim Investigational Site
    • Maryland
      • Annapolis, Maryland, Forenede Stater
        • 1160.26.0114 Boehringer Ingelheim Investigational Site
      • Annapolis, Maryland, Forenede Stater
        • 1160.26.0164 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Forenede Stater
        • 1160.26.0023 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Forenede Stater
        • 1160.26.0047 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Forenede Stater
        • 1160.26.0079 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Forenede Stater
        • 1160.26.0186 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Forenede Stater
        • 1160.26.0194 Boehringer Ingelheim Investigational Site
      • Bel Air, Maryland, Forenede Stater
        • 1160.26.0255 Boehringer Ingelheim Investigational Site
      • Columbia, Maryland, Forenede Stater
        • 1160.26.0398 Boehringer Ingelheim Investigational Site
      • Rockville, Maryland, Forenede Stater
        • 1160.26.0177 Boehringer Ingelheim Investigational Site
      • Salisbury, Maryland, Forenede Stater
        • 1160.26.0073 Boehringer Ingelheim Investigational Site
      • Salisbury, Maryland, Forenede Stater
        • 1160.26.0207 Boehringer Ingelheim Investigational Site
      • Takoma Park, Maryland, Forenede Stater
        • 1160.26.0196 Boehringer Ingelheim Investigational Site
      • Towson, Maryland, Forenede Stater
        • 1160.26.0187 Boehringer Ingelheim Investigational Site
      • Westminster, Maryland, Forenede Stater
        • 1160.26.0052 Boehringer Ingelheim Investigational Site
    • Massachusetts
      • Ayer, Massachusetts, Forenede Stater
        • 1160.26.0042 Boehringer Ingelheim Investigational Site
      • Boston, Massachusetts, Forenede Stater
        • 1160.26.0401 Boehringer Ingelheim Investigational Site
      • East Bridgewater, Massachusetts, Forenede Stater
        • 1160.26.0160 Boehringer Ingelheim Investigational Site
      • Haverhill, Massachusetts, Forenede Stater
        • 1160.26.0443 Boehringer Ingelheim Investigational Site
      • Haverhill, Massachusetts, Forenede Stater
        • 1160.26.0452 Boehringer Ingelheim Investigational Site
      • Natick, Massachusetts, Forenede Stater
        • 1160.26.0029 Boehringer Ingelheim Investigational Site
      • Newtown, Massachusetts, Forenede Stater
        • 1160.26.0446 Boehringer Ingelheim Investigational Site
      • North Dartmouth, Massachusetts, Forenede Stater
        • 1160.26.0003 Boehringer Ingelheim Investigational Site
      • Northborough, Massachusetts, Forenede Stater
        • 1160.26.0470 Boehringer Ingelheim Investigational Site
      • Worcester, Massachusetts, Forenede Stater
        • 1160.26.0308 Boehringer Ingelheim Investigational Site
    • Michigan
      • Bloomfield Hills, Michigan, Forenede Stater
        • 1160.26.0141 Boehringer Ingelheim Investigational Site
      • Detroit, Michigan, Forenede Stater
        • 1160.26.0225 Boehringer Ingelheim Investigational Site
      • Grand Blanc, Michigan, Forenede Stater
        • 1160.26.0154 Boehringer Ingelheim Investigational Site
      • Grand Rapids, Michigan, Forenede Stater
        • 1160.26.0030 Boehringer Ingelheim Investigational Site
      • Kalamazoo, Michigan, Forenede Stater
        • 1160.26.0171 Boehringer Ingelheim Investigational Site
      • Lapeer, Michigan, Forenede Stater
        • 1160.26.0205 Boehringer Ingelheim Investigational Site
      • Muskegon, Michigan, Forenede Stater
        • 1160.26.0279 Boehringer Ingelheim Investigational Site
      • Petoskey, Michigan, Forenede Stater
        • 1160.26.0445 Boehringer Ingelheim Investigational Site
      • Rochester Hills, Michigan, Forenede Stater
        • 1160.26.0274 Boehringer Ingelheim Investigational Site
      • Saginaw, Michigan, Forenede Stater
        • 1160.26.0165 Boehringer Ingelheim Investigational Site
      • Troy, Michigan, Forenede Stater
        • 1160.26.0020 Boehringer Ingelheim Investigational Site
      • Ypsilanti, Michigan, Forenede Stater
        • 1160.26.0188 Boehringer Ingelheim Investigational Site
    • Minnesota
      • Minneapolis, Minnesota, Forenede Stater
        • 1160.26.0131 Boehringer Ingelheim Investigational Site
      • Minneapolis, Minnesota, Forenede Stater
        • 1160.26.0421 Boehringer Ingelheim Investigational Site
      • Robbinsdale, Minnesota, Forenede Stater
        • 1160.26.0202 Boehringer Ingelheim Investigational Site
      • Saint Paul, Minnesota, Forenede Stater
        • 1160.26.0101 Boehringer Ingelheim Investigational Site
    • Mississippi
      • Gulfport, Mississippi, Forenede Stater
        • 1160.26.0086 Boehringer Ingelheim Investigational Site
      • Tupelo, Mississippi, Forenede Stater
        • 1160.26.0119 Boehringer Ingelheim Investigational Site
    • Missouri
      • Columbia, Missouri, Forenede Stater
        • 1160.26.0055 Boehringer Ingelheim Investigational Site
      • Columbia, Missouri, Forenede Stater
        • 1160.26.0172 Boehringer Ingelheim Investigational Site
      • Kansas City, Missouri, Forenede Stater
        • 1160.26.0257 Boehringer Ingelheim Investigational Site
      • Kansas City, Missouri, Forenede Stater
        • 1160.26.0266 Boehringer Ingelheim Investigational Site
      • Saint Charles, Missouri, Forenede Stater
        • 1160.26.0336 Boehringer Ingelheim Investigational Site
      • Saint Louis, Missouri, Forenede Stater
        • 1160.26.0249 Boehringer Ingelheim Investigational Site
    • Montana
      • Kalispell, Montana, Forenede Stater
        • 1160.26.0027 Boehringer Ingelheim Investigational Site
    • Nebraska
      • Alliance, Nebraska, Forenede Stater
        • 1160.26.0128 Boehringer Ingelheim Investigational Site
      • Omaha, Nebraska, Forenede Stater
        • 1160.26.0110 Boehringer Ingelheim Investigational Site
      • Papillion, Nebraska, Forenede Stater
        • 1160.26.0355 Boehringer Ingelheim Investigational Site
    • Nevada
      • Henderson, Nevada, Forenede Stater
        • 1160.26.0346 Boehringer Ingelheim Investigational Site
      • Las Vegas, Nevada, Forenede Stater
        • 1160.26.0066 Boehringer Ingelheim Investigational Site
      • Las Vegas, Nevada, Forenede Stater
        • 1160.26.0174 Boehringer Ingelheim Investigational Site
      • Las Vegas, Nevada, Forenede Stater
        • 1160.26.0430 Boehringer Ingelheim Investigational Site
    • New Hampshire
      • Lebanon, New Hampshire, Forenede Stater
        • 1160.26.0190 Boehringer Ingelheim Investigational Site
    • New Jersey
      • Browns Mills, New Jersey, Forenede Stater
        • 1160.26.0142 Boehringer Ingelheim Investigational Site
      • Cherry Hill, New Jersey, Forenede Stater
        • 1160.26.0125 Boehringer Ingelheim Investigational Site
      • Elmer, New Jersey, Forenede Stater
        • 1160.26.0432 Boehringer Ingelheim Investigational Site
      • Englewood, New Jersey, Forenede Stater
        • 1160.26.0448 Boehringer Ingelheim Investigational Site
      • Flemington, New Jersey, Forenede Stater
        • 1160.26.0248 Boehringer Ingelheim Investigational Site
      • Haddon Heights, New Jersey, Forenede Stater
        • 1160.26.0244 Boehringer Ingelheim Investigational Site
      • New Brunswick, New Jersey, Forenede Stater
        • 1160.26.0243 Boehringer Ingelheim Investigational Site
      • Oakland, New Jersey, Forenede Stater
        • 1160.26.0478 Boehringer Ingelheim Investigational Site
      • Ocean City, New Jersey, Forenede Stater
        • 1160.26.0392 Boehringer Ingelheim Investigational Site
      • Paterson, New Jersey, Forenede Stater
        • 1160.26.0472 Boehringer Ingelheim Investigational Site
      • Voorhees, New Jersey, Forenede Stater
        • 1160.26.0221 Boehringer Ingelheim Investigational Site
      • Westwood, New Jersey, Forenede Stater
        • 1160.26.0254 Boehringer Ingelheim Investigational Site
    • New Mexico
      • Albuquerque, New Mexico, Forenede Stater
        • 1160.26.0127 Boehringer Ingelheim Investigational Site
      • Albuquerque, New Mexico, Forenede Stater
        • 1160.26.0423 Boehringer Ingelheim Investigational Site
    • New York
      • Albany, New York, Forenede Stater
        • 1160.26.0476 Boehringer Ingelheim Investigational Site
      • Bronx, New York, Forenede Stater
        • 1160.26.0113 Boehringer Ingelheim Investigational Site
      • Bronx, New York, Forenede Stater
        • 1160.26.0281 Boehringer Ingelheim Investigational Site
      • Buffalo, New York, Forenede Stater
        • 1160.26.0063 Boehringer Ingelheim Investigational Site
      • Cortlandt Manor, New York, Forenede Stater
        • 1160.26.0044 Boehringer Ingelheim Investigational Site
      • Flushing, New York, Forenede Stater
        • 1160.26.0373 Boehringer Ingelheim Investigational Site
      • Garden City, New York, Forenede Stater
        • 1160.26.0045 Boehringer Ingelheim Investigational Site
      • Kingston, New York, Forenede Stater
        • 1160.26.0251 Boehringer Ingelheim Investigational Site
      • Mineola, New York, Forenede Stater
        • 1160.26.0229 Boehringer Ingelheim Investigational Site
      • Mineola, New York, Forenede Stater
        • 1160.26.0451 Boehringer Ingelheim Investigational Site
      • New Hyde Park, New York, Forenede Stater
        • 1160.26.0090 Boehringer Ingelheim Investigational Site
      • New Rochelle, New York, Forenede Stater
        • 1160.26.0183 Boehringer Ingelheim Investigational Site
      • New York, New York, Forenede Stater
        • 1160.26.0316 Boehringer Ingelheim Investigational Site
      • North Massapequa, New York, Forenede Stater
        • 1160.26.0146 Boehringer Ingelheim Investigational Site
      • Northport, New York, Forenede Stater
        • 1160.26.0210 Boehringer Ingelheim Investigational Site
      • Poughkeepsie, New York, Forenede Stater
        • 1160.26.0075 Boehringer Ingelheim Investigational Site
      • Rochester, New York, Forenede Stater
        • 1160.26.0197 Boehringer Ingelheim Investigational Site
      • Rochester, New York, Forenede Stater
        • 1160.26.0320 Boehringer Ingelheim Investigational Site
      • Scarsdale, New York, Forenede Stater
        • 1160.26.0064 Boehringer Ingelheim Investigational Site
      • Troy, New York, Forenede Stater
        • 1160.26.0414 Boehringer Ingelheim Investigational Site
      • Watertown, New York, Forenede Stater
        • 1160.26.0356 Boehringer Ingelheim Investigational Site
      • Williamsville, New York, Forenede Stater
        • 1160.26.0039 Boehringer Ingelheim Investigational Site
    • North Carolina
      • Asheville, North Carolina, Forenede Stater
        • 1160.26.0353 Boehringer Ingelheim Investigational Site
      • Charlotte, North Carolina, Forenede Stater
        • 1160.26.0080 Boehringer Ingelheim Investigational Site
      • Charlotte, North Carolina, Forenede Stater
        • 1160.26.0412 Boehringer Ingelheim Investigational Site
      • Gastonia, North Carolina, Forenede Stater
        • 1160.26.0350 Boehringer Ingelheim Investigational Site
      • Greensboro, North Carolina, Forenede Stater
        • 1160.26.0322 Boehringer Ingelheim Investigational Site
      • High Point, North Carolina, Forenede Stater
        • 1160.26.0173 Boehringer Ingelheim Investigational Site
      • Lexington, North Carolina, Forenede Stater
        • 1160.26.0108 Boehringer Ingelheim Investigational Site
      • Pinehurst, North Carolina, Forenede Stater
        • 1160.26.0006 Boehringer Ingelheim Investigational Site
      • Statesville, North Carolina, Forenede Stater
        • 1160.26.0002 Boehringer Ingelheim Investigational Site
      • Statesville, North Carolina, Forenede Stater
        • 1160.26.0069 Boehringer Ingelheim Investigational Site
      • Wilmington, North Carolina, Forenede Stater
        • 1160.26.0372 Boehringer Ingelheim Investigational Site
      • Winston-Salem, North Carolina, Forenede Stater
        • 1160.26.0094 Boehringer Ingelheim Investigational Site
      • Winston-Salem, North Carolina, Forenede Stater
        • 1160.26.0425 Boehringer Ingelheim Investigational Site
    • North Dakota
      • Grand Forks, North Dakota, Forenede Stater
        • 1160.26.0102 Boehringer Ingelheim Investigational Site
      • Jamestown, North Dakota, Forenede Stater
        • 1160.26.0222 Boehringer Ingelheim Investigational Site
    • Ohio
      • Akron, Ohio, Forenede Stater
        • 1160.26.0203 Boehringer Ingelheim Investigational Site
      • Canal Fulton, Ohio, Forenede Stater
        • 1160.26.0434 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Forenede Stater
        • 1160.26.0083 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Forenede Stater
        • 1160.26.0402 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Forenede Stater
        • 1160.26.0426 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Forenede Stater
        • 1160.26.0479 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Forenede Stater
        • 1160.26.0263 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Forenede Stater
        • 1160.26.0480 Boehringer Ingelheim Investigational Site
      • Columbus, Ohio, Forenede Stater
        • 1160.26.0267 Boehringer Ingelheim Investigational Site
      • Dayton, Ohio, Forenede Stater
        • 1160.26.0035 Boehringer Ingelheim Investigational Site
      • Fairview Park, Ohio, Forenede Stater
        • 1160.26.0150 Boehringer Ingelheim Investigational Site
      • Kettering, Ohio, Forenede Stater
        • 1160.26.0201 Boehringer Ingelheim Investigational Site
      • Lorain, Ohio, Forenede Stater
        • 1160.26.0223 Boehringer Ingelheim Investigational Site
      • Lyndhurst, Ohio, Forenede Stater
        • 1160.26.0214 Boehringer Ingelheim Investigational Site
      • Sandusky, Ohio, Forenede Stater
        • 1160.26.0275 Boehringer Ingelheim Investigational Site
      • Westlake, Ohio, Forenede Stater
        • 1160.26.0103 Boehringer Ingelheim Investigational Site
    • Oklahoma
      • Bartlesville, Oklahoma, Forenede Stater
        • 1160.26.0155 Boehringer Ingelheim Investigational Site
      • Tulsa, Oklahoma, Forenede Stater
        • 1160.26.0435 Boehringer Ingelheim Investigational Site
    • Oregon
      • Corvallis, Oregon, Forenede Stater
        • 1160.26.0139 Boehringer Ingelheim Investigational Site
      • Eugene, Oregon, Forenede Stater
        • 1160.26.0325 Boehringer Ingelheim Investigational Site
      • Hillsboro, Oregon, Forenede Stater
        • 1160.26.0078 Boehringer Ingelheim Investigational Site
      • Portland, Oregon, Forenede Stater
        • 1160.26.0245 Boehringer Ingelheim Investigational Site
      • Springfield, Oregon, Forenede Stater
        • 1160.26.0133 Boehringer Ingelheim Investigational Site
    • Pennsylvania
      • Allentown, Pennsylvania, Forenede Stater
        • 1160.26.0301 Boehringer Ingelheim Investigational Site
      • Altoona, Pennsylvania, Forenede Stater
        • 1160.26.0454 Boehringer Ingelheim Investigational Site
      • Camp Hill, Pennsylvania, Forenede Stater
        • 1160.26.0295 Boehringer Ingelheim Investigational Site
      • Hershey, Pennsylvania, Forenede Stater
        • 1160.26.0294 Boehringer Ingelheim Investigational Site
      • Jenkintown, Pennsylvania, Forenede Stater
        • 1160.26.0369 Boehringer Ingelheim Investigational Site
      • Jersey Shore, Pennsylvania, Forenede Stater
        • 1160.26.0303 Boehringer Ingelheim Investigational Site
      • Lancaster, Pennsylvania, Forenede Stater
        • 1160.26.0431 Boehringer Ingelheim Investigational Site
      • Langhorne, Pennsylvania, Forenede Stater
        • 1160.26.0168 Boehringer Ingelheim Investigational Site
      • Meadowbrook, Pennsylvania, Forenede Stater
        • 1160.26.0293 Boehringer Ingelheim Investigational Site
      • Newton, Pennsylvania, Forenede Stater
        • 1160.26.0025 Boehringer Ingelheim Investigational Site
      • Norristown, Pennsylvania, Forenede Stater
        • 1160.26.0394 Boehringer Ingelheim Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater
        • 1160.26.0158 Boehringer Ingelheim Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater
        • 1160.26.0181 Boehringer Ingelheim Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater
        • 1160.26.0416 Boehringer Ingelheim Investigational Site
      • Pittsburgh, Pennsylvania, Forenede Stater
        • 1160.26.0344 Boehringer Ingelheim Investigational Site
      • Pittsburgh, Pennsylvania, Forenede Stater
        • 1160.26.0466 Boehringer Ingelheim Investigational Site
      • Sellersville, Pennsylvania, Forenede Stater
        • 1160.26.0208 Boehringer Ingelheim Investigational Site
      • Uniontown, Pennsylvania, Forenede Stater
        • 1160.26.0465 Boehringer Ingelheim Investigational Site
      • Upland, Pennsylvania, Forenede Stater
        • 1160.26.0400 Boehringer Ingelheim Investigational Site
      • Wynnewood, Pennsylvania, Forenede Stater
        • 1160.26.0032 Boehringer Ingelheim Investigational Site
      • Wyomissing, Pennsylvania, Forenede Stater
        • 1160.26.0067 Boehringer Ingelheim Investigational Site
    • Rhode Island
      • Pawtucket, Rhode Island, Forenede Stater
        • 1160.26.0212 Boehringer Ingelheim Investigational Site
    • South Carolina
      • Beaufort, South Carolina, Forenede Stater
        • 1160.26.0007 Boehringer Ingelheim Investigational Site
      • Charleston, South Carolina, Forenede Stater
        • 1160.26.0383 Boehringer Ingelheim Investigational Site
      • Greenville, South Carolina, Forenede Stater
        • 1160.26.0313 Boehringer Ingelheim Investigational Site
      • Mount Pleasant, South Carolina, Forenede Stater
        • 1160.26.0450 Boehringer Ingelheim Investigational Site
      • Spartanburg, South Carolina, Forenede Stater
        • 1160.26.0166 Boehringer Ingelheim Investigational Site
      • Summerville, South Carolina, Forenede Stater
        • 1160.26.0008 Boehringer Ingelheim Investigational Site
      • West Columbia, South Carolina, Forenede Stater
        • 1160.26.0468 Boehringer Ingelheim Investigational Site
    • South Dakota
      • Rapid City, South Dakota, Forenede Stater
        • 1160.26.0348 Boehringer Ingelheim Investigational Site
    • Tennessee
      • Chattanooga, Tennessee, Forenede Stater
        • 1160.26.0084 Boehringer Ingelheim Investigational Site
      • Germantown, Tennessee, Forenede Stater
        • 1160.26.0062 Boehringer Ingelheim Investigational Site
      • Johnson City, Tennessee, Forenede Stater
        • 1160.26.0370 Boehringer Ingelheim Investigational Site
      • Nashville, Tennessee, Forenede Stater
        • 1160.26.0323 Boehringer Ingelheim Investigational Site
      • Nashville, Tennessee, Forenede Stater
        • 1160.26.0395 Boehringer Ingelheim Investigational Site
      • Oak Ridge, Tennessee, Forenede Stater
        • 1160.26.0474 Boehringer Ingelheim Investigational Site
    • Texas
      • Austin, Texas, Forenede Stater
        • 1160.26.0129 Boehringer Ingelheim Investigational Site
      • Austin, Texas, Forenede Stater
        • 1160.26.0410 Boehringer Ingelheim Investigational Site
      • Dallas, Texas, Forenede Stater
        • 1160.26.0156 Boehringer Ingelheim Investigational Site
      • Fort Worth, Texas, Forenede Stater
        • 1160.26.0315 Boehringer Ingelheim Investigational Site
      • Fort Worth, Texas, Forenede Stater
        • 1160.26.0444 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 1160.26.0447 Boehringer Ingelheim Investigational Site
      • Killeen, Texas, Forenede Stater
        • 1160.26.0483 Boehringer Ingelheim Investigational Site
      • Lubbock, Texas, Forenede Stater
        • 1160.26.0335 Boehringer Ingelheim Investigational Site
      • McKinney, Texas, Forenede Stater
        • 1160.26.0230 Boehringer Ingelheim Investigational Site
      • Plano, Texas, Forenede Stater
        • 1160.26.0467 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Forenede Stater
        • 1160.26.0013 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Forenede Stater
        • 1160.26.0269 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Forenede Stater
        • 1160.26.0307 Boehringer Ingelheim Investigational Site
      • San Marcos, Texas, Forenede Stater
        • 1160.26.0285 Boehringer Ingelheim Investigational Site
      • Tyler, Texas, Forenede Stater
        • 1160.26.0215 Boehringer Ingelheim Investigational Site
      • Tyler, Texas, Forenede Stater
        • 1160.26.0367 Boehringer Ingelheim Investigational Site
    • Virginia
      • Arlington, Virginia, Forenede Stater
        • 1160.26.0195 Boehringer Ingelheim Investigational Site
      • Charlottesville, Virginia, Forenede Stater
        • 1160.26.0453 Boehringer Ingelheim Investigational Site
      • Chesapeake, Virginia, Forenede Stater
        • 1160.26.0053 Boehringer Ingelheim Investigational Site
      • Danville, Virginia, Forenede Stater
        • 1160.26.0098 Boehringer Ingelheim Investigational Site
      • Falls Church, Virginia, Forenede Stater
        • 1160.26.0386 Boehringer Ingelheim Investigational Site
      • Fredericksburg, Virginia, Forenede Stater
        • 1160.26.0428 Boehringer Ingelheim Investigational Site
      • Harrisonburg, Virginia, Forenede Stater
        • 1160.26.0311 Boehringer Ingelheim Investigational Site
      • Newport News, Virginia, Forenede Stater
        • 1160.26.0292 Boehringer Ingelheim Investigational Site
      • Norfolk, Virginia, Forenede Stater
        • 1160.26.0224 Boehringer Ingelheim Investigational Site
      • Salem, Virginia, Forenede Stater
        • 1160.26.0220 Boehringer Ingelheim Investigational Site
      • Winchester, Virginia, Forenede Stater
        • 1160.26.0317 Boehringer Ingelheim Investigational Site
    • Washington
      • Bellevue, Washington, Forenede Stater
        • 1160.26.0287 Boehringer Ingelheim Investigational Site
      • Bellingham, Washington, Forenede Stater
        • 1160.26.0050 Boehringer Ingelheim Investigational Site
      • Burien, Washington, Forenede Stater
        • 1160.26.0040 Boehringer Ingelheim Investigational Site
      • Olympia, Washington, Forenede Stater
        • 1160.26.0298 Boehringer Ingelheim Investigational Site
      • Spokane, Washington, Forenede Stater
        • 1160.26.0250 Boehringer Ingelheim Investigational Site
      • Tacoma, Washington, Forenede Stater
        • 1160.26.0256 Boehringer Ingelheim Investigational Site
      • Wenatchee, Washington, Forenede Stater
        • 1160.26.0024 Boehringer Ingelheim Investigational Site
    • West Virginia
      • Charleston, West Virginia, Forenede Stater
        • 1160.26.0193 Boehringer Ingelheim Investigational Site
      • Clarksburg, West Virginia, Forenede Stater
        • 1160.26.0169 Boehringer Ingelheim Investigational Site
      • Huntington, West Virginia, Forenede Stater
        • 1160.26.0365 Boehringer Ingelheim Investigational Site
    • Wisconsin
      • Elkhorn, Wisconsin, Forenede Stater
        • 1160.26.0072 Boehringer Ingelheim Investigational Site
      • Green Bay, Wisconsin, Forenede Stater
        • 1160.26.0234 Boehringer Ingelheim Investigational Site
      • Madison, Wisconsin, Forenede Stater
        • 1160.26.0099 Boehringer Ingelheim Investigational Site
      • Madison, Wisconsin, Forenede Stater
        • 1160.26.0242 Boehringer Ingelheim Investigational Site
      • Marshfield, Wisconsin, Forenede Stater
        • 1160.26.0359 Boehringer Ingelheim Investigational Site
      • Milwaukee, Wisconsin, Forenede Stater
        • 1160.26.0461 Boehringer Ingelheim Investigational Site
  • Frankrig
      • ABBEVILLE cedex, Frankrig
        • 1160.26.0875A Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882A Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882B Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882C Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882D Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882E Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882G Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882H Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882I Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882K Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0882L Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 1160.26.0884A Boehringer Ingelheim Investigational Site
      • Cholet, Frankrig
        • 1160.26.0887A Boehringer Ingelheim Investigational Site
      • Gap, Frankrig
        • 1160.26.0889A Boehringer Ingelheim Investigational Site
      • Grenoble, Frankrig
        • 1160.26.0888A Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0879A Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0879B Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0879C Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0879E Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0879F Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0879G Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0879H Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0879S Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0880A Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0880F Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0880G Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0880J Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0881A Boehringer Ingelheim Investigational Site
      • Joue les Tours, Frankrig
        • 1160.26.0881D Boehringer Ingelheim Investigational Site
      • Joué les Tours, Frankrig
        • 1160.26.0880B Boehringer Ingelheim Investigational Site
      • Joué les Tours, Frankrig
        • 1160.26.0880C Boehringer Ingelheim Investigational Site
      • Joué les Tours, Frankrig
        • 1160.26.0880D Boehringer Ingelheim Investigational Site
      • Joué les Tours, Frankrig
        • 1160.26.0880E Boehringer Ingelheim Investigational Site
      • Langres, Frankrig
        • 1160.26.0874A Boehringer Ingelheim Investigational Site
      • Langres, Frankrig
        • 1160.26.0874B Boehringer Ingelheim Investigational Site
      • Paris, Frankrig
        • 1160.26.0871A Boehringer Ingelheim Investigational Site
      • TOULOUSE cedex, Frankrig
        • 1160.26.0873A Boehringer Ingelheim Investigational Site
      • Tourcoing, Frankrig
        • 1160.26.0886A Boehringer Ingelheim Investigational Site
      • VALENCIENNES cedex, Frankrig
        • 1160.26.0872A Boehringer Ingelheim Investigational Site
      • Valenciennes, Frankrig
        • 1160.26.0872B Boehringer Ingelheim Investigational Site
      • Valenciennes cedex, Frankrig
        • 1160.26.0872C Boehringer Ingelheim Investigational Site
  • Grækenland
      • Alexandroupolis, Grækenland
        • 1160.26.0908 University Hospital of Alexandroupolis
      • Athens, Grækenland
        • 1160.26.0901 General Hospital "Alexandra", Therapeutic Clinic UOA
      • Athens, Grækenland
        • 1160.26.0906 General Hospital ";Evangelismos"
      • Athens, Grækenland
        • 1160.26.0907 "Pammakaristos" Hospital of Athens
      • Athens, Grækenland
        • 1160.26.0915 "Hippokratio" Hospital of Athens
      • Kalamaria-Thessaloniki, Grækenland
        • 1160.26.0914 2nd IKA Hospital, Thessaloniki
      • Larissa, Grækenland
        • 1160.26.0904 General Hospital of Larissa
      • Larissa, Grækenland
        • 1160.26.0913 University Hospital of Larissa
      • Leivadia, Grækenland
        • 1160.26.0912 General Hospital of Leivadia
      • Thessaloniki, Grækenland
        • 1160.26.0902 General Hospital " Papageorgiou"
      • Thiva, Grækenland
        • 1160.26.0910 General Hospital of Thiva
      • Trikala, Grækenland
        • 1160.26.0903 General Hospital of Trikala
      • Voula - Athens, Grækenland
        • 1160.26.0905 Boehringer Ingelheim Investigational Site
  • Holland
      • Almelo, Holland
        • 1160.26.1344 Boehringer Ingelheim Investigational Site
      • Amsterdam, Holland
        • 1160.26.1331 Boehringer Ingelheim Investigational Site
      • Apeldoorn, Holland
        • 1160.26.1336 Boehringer Ingelheim Investigational Site
      • Breda, Holland
        • 1160.26.1332 Boehringer Ingelheim Investigational Site
      • Den Bosch, Holland
        • 1160.26.1337 Boehringer Ingelheim Investigational Site
      • Den Helder, Holland
        • 1160.26.1349 Boehringer Ingelheim Investigational Site
      • Deventer, Holland
        • 1160.26.1345 Boehringer Ingelheim Investigational Site
      • Dirksland, Holland
        • 1160.26.1360 Boehringer Ingelheim Investigational Site
      • Dordrecht, Holland
        • 1160.26.1348 Boehringer Ingelheim Investigational Site
      • Ede, Holland
        • 1160.26.1340 Boehringer Ingelheim Investigational Site
      • Eindhoven, Holland
        • 1160.26.1358 Boehringer Ingelheim Investigational Site
      • Enschede, Holland
        • 1160.26.1338 Boehringer Ingelheim Investigational Site
      • Goes, Holland
        • 1160.26.1343 Boehringer Ingelheim Investigational Site
      • Gorinchem, Holland
        • 1160.26.1347 Boehringer Ingelheim Investigational Site
      • Groningen, Holland
        • 1160.26.1333 Boehringer Ingelheim Investigational Site
      • Groningen, Holland
        • 1160.26.1355 Boehringer Ingelheim Investigational Site
      • Heerlen, Holland
        • 1160.26.1361 Boehringer Ingelheim Investigational Site
      • Hengelo, Holland
        • 1160.26.1339 Boehringer Ingelheim Investigational Site
      • Hilversum, Holland
        • 1160.26.1346 Boehringer Ingelheim Investigational Site
      • Hoorn, Holland
        • 1160.26.1356 Boehringer Ingelheim Investigational Site
      • Maastricht, Holland
        • 1160.26.1359 Boehringer Ingelheim Investigational Site
      • Meppel, Holland
        • 1160.26.1341 Boehringer Ingelheim Investigational Site
      • Rotterdam, Holland
        • 1160.26.1354 Boehringer Ingelheim Investigational Site
      • Sneek, Holland
        • 1160.26.1351 Boehringer Ingelheim Investigational Site
      • Spiijkenisse, Holland
        • 1160.26.1334 Boehringer Ingelheim Investigational Site
      • Terneuzen, Holland
        • 1160.26.1335 Boehringer Ingelheim Investigational Site
      • Tiel, Holland
        • 1160.26.1353 Boehringer Ingelheim Investigational Site
      • Tilburg, Holland
        • 1160.26.1352 Boehringer Ingelheim Investigational Site
      • Veldhoven, Holland
        • 1160.26.1350 Boehringer Ingelheim Investigational Site
      • Velp, Holland
        • 1160.26.1342 Boehringer Ingelheim Investigational Site
      • Venlo, Holland
        • 1160.26.1357 Boehringer Ingelheim Investigational Site
  • Hong Kong
      • Hong Kong, Hong Kong
        • 1160.26.1001 Boehringer Ingelheim Investigational Site
      • Hong Kong, Hong Kong
        • 1160.26.1002 Boehringer Ingelheim Investigational Site
      • Kowloon, Hong Kong
        • 1160.26.1003 Boehringer Ingelheim Investigational Site
      • Kowloon, Hong Kong
        • 1160.26.1004 Boehringer Ingelheim Investigational Site
  • Indien
      • Ahmedabad, Indien
        • 1160.26.1056 Boehringer Ingelheim Investigational Site
      • Ahmedabad, Indien
        • 1160.26.1057 Boehringer Ingelheim Investigational Site
      • Bangalore, Indien
        • 1160.26.1064 Boehringer Ingelheim Investigational Site
      • Bangalore, Indien
        • 1160.26.1065 Boehringer Ingelheim Investigational Site
      • Bikaner, Indien
        • 1160.26.1071 Boehringer Ingelheim Investigational Site
      • Chennai, Indien
        • 1160.26.1066 Boehringer Ingelheim Investigational Site
      • Coimbatore, Indien
        • 1160.26.1069 Boehringer Ingelheim Investigational Site
      • Hyderabad, Indien
        • 1160.26.1062 Boehringer Ingelheim Investigational Site
      • Indore, Indien
        • 1160.26.1058 Boehringer Ingelheim Investigational Site
      • Jaipur, Indien
        • 1160.26.1053 Boehringer Ingelheim Investigational Site
      • Jaipur, Indien
        • 1160.26.1073 Boehringer Ingelheim Investigational Site
      • Kerala, Indien
        • 1160.26.1067 Boehringer Ingelheim Investigational Site
      • Kottayam, Indien
        • 1160.26.1068 Boehringer Ingelheim Investigational Site
      • Lucknow, Indien
        • 1160.26.1055 Boehringer Ingelheim Investigational Site
      • Ludhiana, Indien
        • 1160.26.1051 Boehringer Ingelheim Investigational Site
      • Mumbai, Indien
        • 1160.26.1060 Boehringer Ingelheim Investigational Site
      • Mysore, Indien
        • 1160.26.1072 Boehringer Ingelheim Investigational Site
      • Nagpur, Indien
        • 1160.26.1059 Boehringer Ingelheim Investigational Site
      • New Delhi, Indien
        • 1160.26.1052 Boehringer Ingelheim Investigational Site
      • Pune, Indien
        • 1160.26.1070 Boehringer Ingelheim Investigational Site
  • Israel
      • Afula, Israel
        • 1160.26.1110 Boehringer Ingelheim Investigational Site
      • Afula, Israel
        • 1160.26.1121 Boehringer Ingelheim Investigational Site
      • Ashkelon, Israel
        • 1160.26.1111 Boehringer Ingelheim Investigational Site
      • Be´er Scheva, Israel
        • 1160.26.1102 Boehringer Ingelheim Investigational Site
      • Givatayim, Israel
        • 1160.26.1117 Boehringer Ingelheim Investigational Site
      • Hadera, Israel
        • 1160.26.1112 Boehringer Ingelheim Investigational Site
      • Haifa, Israel
        • 1160.26.1091 Boehringer Ingelheim Investigational Site
      • Haifa, Israel
        • 1160.26.1113 Boehringer Ingelheim Investigational Site
      • Haifa, Israel
        • 1160.26.1114 Boehringer Ingelheim Investigational Site
      • Haifa, Israel
        • 1160.26.1116 Boehringer Ingelheim Investigational Site
      • Haifa, Israel
        • 1160.26.1118 Boehringer Ingelheim Investigational Site
      • Holon, Israel
        • 1160.26.1105 Boehringer Ingelheim Investigational Site
      • Jerusalem, Israel
        • 1160.26.1097 Boehringer Ingelheim Investigational Site
      • Jerusalem, Israel
        • 1160.26.1101 Boehringer Ingelheim Investigational Site
      • Jerusalem, Israel
        • 1160.26.1104 Boehringer Ingelheim Investigational Site
      • Jerusalem, Israel
        • 1160.26.1106 Boehringer Ingelheim Investigational Site
      • Kfar Saba, Israel
        • 1160.26.1119 Boehringer Ingelheim Investigational Site
      • Nazareth, Israel
        • 1160.26.1115 Boehringer Ingelheim Investigational Site
      • Petah Tikva, Israel
        • 1160.26.1096 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Israel
        • 1160.26.1093 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Israel
        • 1160.26.1094 Boehringer Ingelheim Investigational Site
      • Ramat Gan, Israel
        • 1160.26.1095 Boehringer Ingelheim Investigational Site
      • Rehovot, Israel
        • 1160.26.1100 Boehringer Ingelheim Investigational Site
      • Safed, Israel
        • 1160.26.1103 Boehringer Ingelheim Investigational Site
      • Tel Hashomer, Israel
        • 1160.26.1092 Boehringer Ingelheim Investigational Site
      • Tel Hashomer, Israel
        • 1160.26.1098 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israel
        • 1160.26.1107 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israel
        • 1160.26.1108 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israel
        • 1160.26.1109 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israel
        • 1160.26.1120 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israel
        • 1160.26.1122 Boehringer Ingelheim Investigational Site
      • Zerifin, Israel
        • 1160.26.1099 Boehringer Ingelheim Investigational Site
  • Italien
      • Arezzo, Italien
        • 1160.26.1169 Boehringer Ingelheim Investigational Site
      • Ascoli Piceno, Italien
        • 1160.26.1172 Boehringer Ingelheim Investigational Site
      • Bentivoglio (BO), Italien
        • 1160.26.1180 Boehringer Ingelheim Investigational Site
      • Bologna, Italien
        • 1160.26.1161 Boehringer Ingelheim Investigational Site
      • Castelnuovo Garfagnana, Italien
        • 1160.26.1163 Boehringer Ingelheim Investigational Site
      • Chieti, Italien
        • 1160.26.1178 Boehringer Ingelheim Investigational Site
      • Colleferro, Italien
        • 1160.26.1171 Boehringer Ingelheim Investigational Site
      • Cremona, Italien
        • 1160.26.1174 Boehringer Ingelheim Investigational Site
      • Eboli, Italien
        • 1160.26.1167 Boehringer Ingelheim Investigational Site
      • Isernia, Italien
        • 1160.26.1168 Boehringer Ingelheim Investigational Site
      • Legnago, Italien
        • 1160.26.1162 Boehringer Ingelheim Investigational Site
      • Mantova, Italien
        • 1160.26.1177 Boehringer Ingelheim Investigational Site
      • Perugia SAN Sisto, Italien
        • 1160.26.1165 Boehringer Ingelheim Investigational Site
      • Roma, Italien
        • 1160.26.1175 Boehringer Ingelheim Investigational Site
      • San Bonifacio, Italien
        • 1160.26.1181 Boehringer Ingelheim Investigational Site
      • San Daniele Del Friuli, Italien
        • 1160.26.1173 Boehringer Ingelheim Investigational Site
      • Sassari, Italien
        • 1160.26.1170 Boehringer Ingelheim Investigational Site
      • Sassari, Italien
        • 1160.26.1176 Boehringer Ingelheim Investigational Site
  • Japan
      • Abeno-ku, Osaka, Osaka, Japan
        • 1160.26.1204 Boehringer Ingelheim Investigational Site
      • Aki-gun, Hiroshima, Japan
        • 1160.26.1209 Boehringer Ingelheim Investigational Site
      • Aoba-ku, Sendai, Miyagi, Japan
        • 1160.26.1193 Boehringer Ingelheim Investigational Site
      • Chuo-ku, Fukuoka, Fukuoka, Japan
        • 1160.26.1211 Boehringer Ingelheim Investigational Site
      • Chuo-ku, Fukuoka, Fukuoka, Japan
        • 1160.26.1225 Boehringer Ingelheim Investigational Site
      • Chuo-ku, Kobe, Hyogo, Japan
        • 1160.26.1221 Boehringer Ingelheim Investigational Site
      • Chuo-ku, Osaka, Osaka, Japan
        • 1160.26.1219 Boehringer Ingelheim Investigational Site
      • Fujioka-shi , Gunma-ken, Japan
        • 1160.26.1229 Boehringer Ingelheim Investigational Site
      • Fukushima-shi,Fukushima-ken, Japan
        • 1160.26.1232 Boehringer Ingelheim Investigational Site
      • Higashimatsushimashi, Miyagi-ken, Japan
        • 1160.26.1228 Boehringer Ingelheim Investigational Site
      • Himeji, Hyogo, Japan
        • 1160.26.1208 Boehringer Ingelheim Investigational Site
      • Iida, Nagano, Japan
        • 1160.26.1214 Boehringer Ingelheim Investigational Site
      • Isesaki-shi,Gunma, Japan
        • 1160.26.1240 Boehringer Ingelheim Investigational Site
      • Iwakuni, Yamaguchi, Japan
        • 1160.26.1224 Boehringer Ingelheim Investigational Site
      • Izumi-ku, Sendai, Miyagi, Japan
        • 1160.26.1194 Boehringer Ingelheim Investigational Site
      • Kamigyo-ku, Kyoto, Japan
        • 1160.26.1241 Boehringer Ingelheim Investigational Site
      • Kawachinagano, Osaka, Japan
        • 1160.26.1220 Boehringer Ingelheim Investigational Site
      • Kita-ku, Osaka, Osaka, Japan
        • 1160.26.1203 Boehringer Ingelheim Investigational Site
      • Kita-ku, Sakai, Osaka, Japan
        • 1160.26.1207 Boehringer Ingelheim Investigational Site
      • Komatsu-shi,Ishikawa -ken, Japan
        • 1160.26.1231 Boehringer Ingelheim Investigational Site
      • Kyoto-shi,Kyoto, Japan
        • 1160.26.1233 Boehringer Ingelheim Investigational Site
      • Matsumoto, Nagano, Japan
        • 1160.26.1242 Boehringer Ingelheim Investigational Site
      • Minami-ku, Fukuoka, Fukuoka, Japan
        • 1160.26.1210 Boehringer Ingelheim Investigational Site
      • Minato, Tokyo, Japan
        • 1160.26.1218 Boehringer Ingelheim Investigational Site
      • Minato-ku, Nagoya, Aichi, Japan
        • 1160.26.1200 Boehringer Ingelheim Investigational Site
      • Minato-ku, Nagoya, Aichi, Japan
        • 1160.26.1201 Boehringer Ingelheim Investigational Site
      • Narashino, Chiba, Japan
        • 1160.26.1216 Boehringer Ingelheim Investigational Site
      • Nishinomiya-shi,Hyogo, Japan
        • 1160.26.1237 Boehringer Ingelheim Investigational Site
      • Okayama, Okayama, Japan
        • 1160.26.1223 Boehringer Ingelheim Investigational Site
      • Oota, Tokyo, Japan
        • 1160.26.1197 Boehringer Ingelheim Investigational Site
      • Otaru, Hokkaido, Japan
        • 1160.26.1212 Boehringer Ingelheim Investigational Site
      • Sagamihara, Kanagawa-ken, Japan
        • 1160.26.1230 Boehringer Ingelheim Investigational Site
      • Sapporo-shi,Hokkai-do, Japan
        • 1160.26.1238 Boehringer Ingelheim Investigational Site
      • Shibuya, Tokyo, Japan
        • 1160.26.1217 Boehringer Ingelheim Investigational Site
      • Shinjuku, Tokyo, Japan
        • 1160.26.1196 Boehringer Ingelheim Investigational Site
      • Shiroishi-ku, Sapporo, Hokkaido, Japan
        • 1160.26.1191 Boehringer Ingelheim Investigational Site
      • Shiroishi-ku, Sapporo, Hokkaido, Japan
        • 1160.26.1192 Boehringer Ingelheim Investigational Site
      • Suita, Osaka, Japan
        • 1160.26.1206 Boehringer Ingelheim Investigational Site
      • Suita-shi, Osaka, Japan
        • 1160.26.1235 Boehringer Ingelheim Investigational Site
      • Suita-shi, Osaka, Japan
        • 1160.26.1236 Boehringer Ingelheim Investigational Site
      • Sumiyoshi-ku, Osaka, Osaka, Japan
        • 1160.26.1205 Boehringer Ingelheim Investigational Site
      • Takatsuki-shi,Osaka, Japan
        • 1160.26.1234 Boehringer Ingelheim Investigational Site
      • Tokorozawa, Saitama, Japan
        • 1160.26.1215 Boehringer Ingelheim Investigational Site
      • Totsuka-ku, Yokohama, Kanagawa, Japan
        • 1160.26.1198 Boehringer Ingelheim Investigational Site
      • Tsuchiura, Ibaragi, Japan
        • 1160.26.1195 Boehringer Ingelheim Investigational Site
      • Ueda, Nagano, Japan
        • 1160.26.1199 Boehringer Ingelheim Investigational Site
      • Wakayama, Wakayama, Japan
        • 1160.26.1222 Boehringer Ingelheim Investigational Site
      • Yanagawa, Fukuoka, Japan
        • 1160.26.1227 Boehringer Ingelheim Investigational Site
      • Yao, Osaka, Japan
        • 1160.26.1243 Boehringer Ingelheim Investigational Site
  • Kalkun
      • Adana, Kalkun
        • 1160.26.1715 Boehringer Ingelheim Investigational Site
      • Ankara, Kalkun
        • 1160.26.1711 Boehringer Ingelheim Investigational Site
      • Ankara, Kalkun
        • 1160.26.1713 Gazi Universitesi Tip Fakultesi Kardiyoloji Abd
      • Izmir, Kalkun
        • 1160.26.1714 Dokuz Eylul Universitesi Tip Fakultesi
  • Kina
      • Beijing, Kina
        • 1160.26.0771 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 1160.26.0772 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 1160.26.0773 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 1160.26.0774 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 1160.26.0775 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 1160.26.0783 Boehringer Ingelheim Investigational Site
      • Hangzhou, Kina
        • 1160.26.0784 Boehringer Ingelheim Investigational Site
      • Harbin, Kina
        • 1160.26.0776 Boehringer Ingelheim Investigational Site
      • QingDao, Kina
        • 1160.26.0778 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 1160.26.0781 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 1160.26.0782 Boehringer Ingelheim Investigational Site
      • Shenyang, Kina
        • 1160.26.0777 Boehringer Ingelheim Investigational Site
      • Shijiazhuang, Kina
        • 1160.26.0780 Boehringer Ingelheim Investigational Site
  • Korea, Republikken
      • Busan, Korea, Republikken
        • 1160.26.1585 Boehringer Ingelheim Investigational Site
      • Chungchungnam-Do, Korea, Republikken
        • 1160.26.1586 Boehringer Ingelheim Investigational Site
      • Daegu, Korea, Republikken
        • 1160.26.1584 Boehringer Ingelheim Investigational Site
      • Daegu, Korea, Republikken
        • 1160.26.1591 Boehringer Ingelheim Investigational Site
      • Gwangju, Korea, Republikken
        • 1160.26.1590 Boehringer Ingelheim Investigational Site
      • Incheon, Korea, Republikken
        • 1160.26.1581 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 1160.26.1582 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 1160.26.1583 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 1160.26.1588 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 1160.26.1589 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 1160.26.1592 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 1160.26.1593 Boehringer Ingelheim Investigational Site
  • Malaysia
      • Kajang,Selangor, Malaysia
        • 1160.26.1297 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malaysia
        • 1160.26.1291 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malaysia
        • 1160.26.1292 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malaysia
        • 1160.26.1294 Boehringer Ingelheim Investigational Site
      • Kuching, Malaysia
        • 1160.26.1293 Boehringer Ingelheim Investigational Site
      • Penang, Malaysia
        • 1160.26.1295 Boehringer Ingelheim Investigational Site
      • Penang, Malaysia
        • 1160.26.1296 Boehringer Ingelheim Investigational Site
  • Mexico
      • Durango, Mexico
        • 1160.26.1318 Hospital General "Dr. Santiago Ramón y Cajal
      • Guadalajara, Mexico
        • 1160.26.1311 Hospital Mexico-Americano
      • Guadalajara, Mexico
        • 1160.26.1317 hOSPITAL bERNARDETTE
      • Mexico, Mexico
        • 1160.26.1312 Hospital de Jesus
      • Mexico, Mexico
        • 1160.26.1319 Instituto Nacional de Cardiologia
      • México, Mexico
        • 1160.26.1314 Hospital 1o. de Octubre
      • San Luis Potosí, Mexico
        • 1160.26.1313 Hosp. Angeles Centro Medico del Potosi
      • San Luis Potosí, Mexico
        • 1160.26.1322 Hospital Central "Dr. Ignacio Morones Prieto"
  • Norge
      • Gjøvik, Norge
        • 1160.26.1396 Boehringer Ingelheim Investigational Site
      • Moss, Norge
        • 1160.26.1393 Boehringer Ingelheim Investigational Site
      • Nordbyhagen, Norge
        • 1160.26.1395 Boehringer Ingelheim Investigational Site
      • Oslo, Norge
        • 1160.26.1391 Boehringer Ingelheim Investigational Site
      • Oslo, Norge
        • 1160.26.1392 Boehringer Ingelheim Investigational Site
      • Oslo, Norge
        • 1160.26.1397 Boehringer Ingelheim Investigational Site
      • RUD, Norge
        • 1160.26.1394 Boehringer Ingelheim Investigational Site
  • Peru
      • Bella Vista, Peru
        • 1160.26.1415 Hospital Alberto Sabogal
      • Jesús María, Peru
        • 1160.26.1411 Clinica San Felipe
      • San Isidro, Peru
        • 1160.26.1412 Clínica Anglo Americana
      • San Martín de Porres, Peru
        • 1160.26.1413 Hospital Cayetano Heredia
      • Urbanización Sto Tomas De San Borja, Peru
        • 1160.26.1414 Clínica Vesalio
  • Polen
      • Gdynia, Polen
        • 1160.26.1436 Boehringer Ingelheim Investigational Site
      • Gdynia, Polen
        • 1160.26.1438 Boehringer Ingelheim Investigational Site
      • Gdynia Redlowo, Polen
        • 1160.26.1437 Boehringer Ingelheim Investigational Site
      • Katowice, Polen
        • 1160.26.1435 Boehringer Ingelheim Investigational Site
      • Krakow, Polen
        • 1160.26.1439 Boehringer Ingelheim Investigational Site
      • Krakow, Polen
        • 1160.26.1440 Boehringer Ingelheim Investigational Site
      • Pulawy, Polen
        • 1160.26.1433 Boehringer Ingelheim Investigational Site
      • Warsaw, Polen
        • 1160.26.1431 Boehringer Ingelheim Investigational Site
      • Warsaw, Polen
        • 1160.26.1432 Boehringer Ingelheim Investigational Site
      • Zabrze, Polen
        • 1160.26.1434 Boehringer Ingelheim Investigational Site
  • Portugal
      • Amadora, Portugal
        • 1160.26.1456 Boehringer Ingelheim Investigational Site
      • Carnaxide, Portugal
        • 1160.26.1451 Boehringer Ingelheim Investigational Site
      • Coimbra, Portugal
        • 1160.26.1454 Boehringer Ingelheim Investigational Site
      • Coimbra, Portugal
        • 1160.26.1459 Boehringer Ingelheim Investigational Site
      • Covilhã, Portugal
        • 1160.26.1457 Boehringer Ingelheim Investigational Site
      • Lisboa, Portugal
        • 1160.26.1453 Boehringer Ingelheim Investigational Site
      • Lisboa, Portugal
        • 1160.26.1458 Boehringer Ingelheim Investigational Site
      • Porto, Portugal
        • 1160.26.1455 Boehringer Ingelheim Investigational Site
      • Setúbal, Portugal
        • 1160.26.1452 Boehringer Ingelheim Investigational Site
  • Rumænien
      • Bucharest, Rumænien
        • 1160.26.1471 Boehringer Ingelheim Investigational Site
      • Bucharest, Rumænien
        • 1160.26.1472 Boehringer Ingelheim Investigational Site
      • Cluj Napoca, Rumænien
        • 1160.26.1478 Boehringer Ingelheim Investigational Site
  • Schweiz
      • Basel, Schweiz
        • 1160.26.1652 Boehringer Ingelheim Investigational Site
      • Bellinzona, Schweiz
        • 1160.26.1655 Boehringer Ingelheim Investigational Site
      • Bern, Schweiz
        • 1160.26.1651 Boehringer Ingelheim Investigational Site
      • Lugano, Schweiz
        • 1160.26.1654 Boehringer Ingelheim Investigational Site
  • Singapore
      • Singapore, Singapore
        • 1160.26.1531 Boehringer Ingelheim Investigational Site
      • Singapore, Singapore
        • 1160.26.1532 Boehringer Ingelheim Investigational Site
  • Slovakiet
      • Banska Bystrica, Slovakiet
        • 1160.26.1548 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovakiet
        • 1160.26.1541 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovakiet
        • 1160.26.1542 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovakiet
        • 1160.26.1543 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovakiet
        • 1160.26.1544 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovakiet
        • 1160.26.1545 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovakiet
        • 1160.26.1546 Boehringer Ingelheim Investigational Site
      • Kosice, Slovakiet
        • 1160.26.1549 Boehringer Ingelheim Investigational Site
      • Kosice, Slovakiet
        • 1160.26.1550 Boehringer Ingelheim Investigational Site
      • Zilina, Slovakiet
        • 1160.26.1547 Boehringer Ingelheim Investigational Site
  • Spanien
      • Barcelona, Spanien
        • 1160.26.1601 Boehringer Ingelheim Investigational Site
      • Cadiz, Spanien
        • 1160.26.1606 Boehringer Ingelheim Investigational Site
      • Fuenlabrada (Madrid), Spanien
        • 1160.26.1607 Boehringer Ingelheim Investigational Site
      • Leganés, Madrid, Spanien
        • 1160.26.1604 Boehringer Ingelheim Investigational Site
      • Madrid, Spanien
        • 1160.26.1603 Boehringer Ingelheim Investigational Site
      • Madrid, Spanien
        • 1160.26.1608 Boehringer Ingelheim Investigational Site
      • Madrid-San Lorenzo Del Escorial, Spanien
        • 1160.26.1609 Boehringer Ingelheim Investigational Site
      • Móstoles (Madrid), Spanien
        • 1160.26.1605 Boehringer Ingelheim Investigational Site
      • Sabadell, Spanien
        • 1160.26.1602 Boehringer Ingelheim Investigational Site
  • Sverige
      • Göteboerg, Sverige
        • 1160.26.1633 Sahlgrenska Sjukhuset
      • Jönköping, Sverige
        • 1160.26.1629 AVK-mott, Spec.M1, Länssjukhuset Ryhov
      • Linköping, Sverige
        • 1160.26.1631 Universitetssjukhuset i Linköping
      • Malmö, Sverige
        • 1160.26.1627 Hjärtmott. ING 35, Malmö Universitetssjukhus MAS
      • Norrköping, Sverige
        • 1160.26.1625 Hjärtmott./Medicinkliniken, Vrinnevisjukhuset
      • Nässjö, Sverige
        • 1160.26.1628 Rådhusg. 29, Lars Mörlids Läkarmottagning
      • Stockholm, Sverige
        • 1160.26.1626 Hjärtkärllaboratoriet, Danderyds Sjukhus AB
      • Stockholm, Sverige
        • 1160.26.1632 Capio S:t Görans Sjukhus
      • Stockholm, Sverige
        • 1160.26.1634 Södersjukhuset
      • Umeå, Sverige
        • 1160.26.1624 Klin. forskningscentrum, Norrlands Universitetssjukhus
      • Uppsala, Sverige
        • 1160.26.1621 Kardiologiska kliniken, Akademiska Sjukhuset
      • Uppsala, Sverige
        • 1160.26.1635 UCR/Uppsala
      • Västerås, Sverige
        • 1160.26.1622 Hjärtmottagningen, Centrallasarettet
      • Örebro, Sverige
        • 1160.26.1623 Kardiologiska kliniken, Universitetssjukhuset
  • Sydafrika
      • Bloemfontein, Sydafrika
        • 1160.26.1562 Boehringer Ingelheim Investigational Site
      • Boksburg, Sydafrika
        • 1160.26.1569 Boehringer Ingelheim Investigational Site
      • Cape Town, Sydafrika
        • 1160.26.1561 Boehringer Ingelheim Investigational Site
      • Johannesburg, Sydafrika
        • 1160.26.1564 Boehringer Ingelheim Investigational Site
      • Johannesburg, Sydafrika
        • 1160.26.1567 Boehringer Ingelheim Investigational Site
      • Johannesburg, Sydafrika
        • 1160.26.1568 Boehringer Ingelheim Investigational Site
      • Pretoria, Sydafrika
        • 1160.26.1566 Boehringer Ingelheim Investigational Site
      • Randburg, Sydafrika
        • 1160.26.1563 Boehringer Ingelheim Investigational Site
      • Somerset West, Sydafrika
        • 1160.26.1565 Boehringer Ingelheim Investigational Site
  • Taiwan
      • Changhua County, Taiwan
        • 1160.26.1680 Boehringer Ingelheim Investigational Site
      • Hualien, Taiwan
        • 1160.26.1683 Boehringer Ingelheim Investigational Site
      • Kaohsiung, Taiwan
        • 1160.26.1682 Boehringer Ingelheim Investigational Site
      • Taichung, Taiwan
        • 1160.26.1679 China Medical University Hospital
      • Tainan, Taiwan
        • 1160.26.1681 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.26.1671 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.26.1672 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.26.1673 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.26.1674 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.26.1675 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.26.1676 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 1160.26.1677 Boehringer Ingelheim Investigational Site
      • Taoyuan, Taiwan
        • 1160.26.1678 Boehringer Ingelheim Investigational Site
  • Thailand
      • Bangkok, Thailand
        • 1160.26.1701 Boehringer Ingelheim Investigational Site
      • Bangkok, Thailand
        • 1160.26.1702 Boehringer Ingelheim Investigational Site
      • Chiangmai, Thailand
        • 1160.26.1703 Boehringer Ingelheim Investigational Site
      • Khon Kaen, Thailand
        • 1160.26.1704 Boehringer Ingelheim Investigational Site
      • Muang Nakhonratchasima, Thailand
        • 1160.26.1705 Boehringer Ingelheim Investigational Site
  • Tjekkiet
      • Brno, Tjekkiet
        • 1160.26.0815 Boehringer Ingelheim Investigational Site
      • Brno, Tjekkiet
        • 1160.26.0816 Boehringer Ingelheim Investigational Site
      • Ostrava 1, Tjekkiet
        • 1160.26.0820 Boehringer Ingelheim Investigational Site
      • Pardubice, Tjekkiet
        • 1160.26.0818 Boehringer Ingelheim Investigational Site
      • Plzen-Bory, Tjekkiet
        • 1160.26.0814 Boehringer Ingelheim Investigational Site
      • Pragha 9, Tjekkiet
        • 1160.26.0813 Boehringer Ingelheim Investigational Site
      • Prague 5, Tjekkiet
        • 1160.26.0811 Boehringer Ingelheim Investigational Site
      • Praha 6, Tjekkiet
        • 1160.26.0812 Boehringer Ingelheim Investigational Site
      • Pribram, Tjekkiet
        • 1160.26.0817 Boehringer Ingelheim Investigational Site
      • Usti nad Orlici, Tjekkiet
        • 1160.26.0819 Boehringer Ingelheim Investigational Site
  • Tyskland
      • Berlin, Tyskland
        • 1160.26.0932 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 1160.26.0948 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 1160.26.0962 Boehringer Ingelheim Investigational Site
      • Bochum, Tyskland
        • 1160.26.0940 Boehringer Ingelheim Investigational Site
      • Coburg, Tyskland
        • 1160.26.0936 Boehringer Ingelheim Investigational Site
      • Dachau, Tyskland
        • 1160.26.0968 Boehringer Ingelheim Investigational Site
      • Dortmund, Tyskland
        • 1160.26.0972 Boehringer Ingelheim Investigational Site
      • Duisburg, Tyskland
        • 1160.26.0957 Boehringer Ingelheim Investigational Site
      • Erlangen, Tyskland
        • 1160.26.0971 Boehringer Ingelheim Investigational Site
      • Eschweiler, Tyskland
        • 1160.26.0965 Boehringer Ingelheim Investigational Site
      • Essen, Tyskland
        • 1160.26.0934 Boehringer Ingelheim Investigational Site
      • Frankfurt/Main, Tyskland
        • 1160.26.0931 Boehringer Ingelheim Investigational Site
      • Heidelberg, Tyskland
        • 1160.26.0943 Boehringer Ingelheim Investigational Site
      • Kassel, Tyskland
        • 1160.26.0955 Boehringer Ingelheim Investigational Site
      • Köln, Tyskland
        • 1160.26.0963 Boehringer Ingelheim Investigational Site
      • Lahr, Tyskland
        • 1160.26.0946 Boehringer Ingelheim Investigational Site
      • Limburg, Tyskland
        • 1160.26.0944 Boehringer Ingelheim Investigational Site
      • Mainz, Tyskland
        • 1160.26.0951 Boehringer Ingelheim Investigational Site
      • Mannheim, Tyskland
        • 1160.26.0933 Boehringer Ingelheim Investigational Site
      • Mannheim, Tyskland
        • 1160.26.0945 Boehringer Ingelheim Investigational Site
      • Mannheim, Tyskland
        • 1160.26.0970 Boehringer Ingelheim Investigational Site
      • München, Tyskland
        • 1160.26.0947 Boehringer Ingelheim Investigational Site
      • München, Tyskland
        • 1160.26.0952 Boehringer Ingelheim Investigational Site
      • Papenburg, Tyskland
        • 1160.26.0941 Boehringer Ingelheim Investigational Site
      • Suhl, Tyskland
        • 1160.26.0959 Boehringer Ingelheim Investigational Site
      • Witten, Tyskland
        • 1160.26.0937 Boehringer Ingelheim Investigational Site
      • Wuppertal, Tyskland
        • 1160.26.0966 Boehringer Ingelheim Investigational Site
  • Ukraine
      • Dnyepropetrovsk, Ukraine
        • 1160.26.1727 Boehringer Ingelheim Investigational Site
      • Kharkiv, Ukraine
        • 1160.26.1726 Boehringer Ingelheim Investigational Site
      • Kharkov, Ukraine
        • 1160.26.1724 Boehringer Ingelheim Investigational Site
      • Kharkov, Ukraine
        • 1160.26.1725 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 1160.26.1721 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 1160.26.1722 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 1160.26.1723 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 1160.26.1728 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 1160.26.1730 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 1160.26.1731 Boehringer Ingelheim Investigational Site
      • Lvov, Ukraine
        • 1160.26.1729 Boehringer Ingelheim Investigational Site
  • Ungarn
      • Budapest, Ungarn
        • 1160.26.1011 Boehringer Ingelheim Investigational Site
      • Budapest, Ungarn
        • 1160.26.1012 Boehringer Ingelheim Investigational Site
      • Budapest, Ungarn
        • 1160.26.1013 Boehringer Ingelheim Investigational Site
      • Budapest, Ungarn
        • 1160.26.1014 Boehringer Ingelheim Investigational Site
      • Budapest, Ungarn
        • 1160.26.1015 Boehringer Ingelheim Investigational Site
      • Budapest, Ungarn
        • 1160.26.1016 Boehringer Ingelheim Investigational Site
      • Gyongyos, Ungarn
        • 1160.26.1020 Boehringer Ingelheim Investigational Site
      • Komarom, Ungarn
        • 1160.26.1017 Boehringer Ingelheim Investigational Site
      • Pecs, Ungarn
        • 1160.26.1018 Boehringer Ingelheim Investigational Site
      • Veszprem, Ungarn
        • 1160.26.1019 Boehringer Ingelheim Investigational Site
  • Østrig
      • Graz, Østrig
        • 1160.26.0543 Boehringer Ingelheim Investigational Site
      • Linz, Østrig
        • 1160.26.0549 Boehringer Ingelheim Investigational Site
      • Wels, Østrig
        • 1160.26.0546 Boehringer Ingelheim Investigational Site
      • Wien, Østrig
        • 1160.26.0541 Boehringer Ingelheim Investigational Site
      • Wien, Østrig
        • 1160.26.0542 Boehringer Ingelheim Investigational Site
      • Wien, Østrig
        • 1160.26.0544 Boehringer Ingelheim Investigational Site
      • Wien, Østrig
        • 1160.26.0545 Boehringer Ingelheim Investigational Site
      • Wien, Østrig
        • 1160.26.0547 Boehringer Ingelheim Investigational Site
      • Wien, Østrig
        • 1160.26.0548 Boehringer Ingelheim Investigational Site
      • Wr. Neustadt, Østrig
        • 1160.26.0550 Boehringer Ingelheim Investigational Site

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inklusionskriterier Patienter med ikke-valvulært atrieflimren (AF), med moderat til høj risiko for slagtilfælde eller systemisk emboli med mindst én yderligere risikofaktor (dvs. tidligere iskæmisk slagtilfælde, TIA eller systemisk emboli, venstre ventrikulær dysfunktion, alder >=75 år, alder >=65 med enten diabetes mellitus, historie med koronararteriesygdom eller hypertension)

Eksklusionskriterier

  1. Prostetiske hjerteklapper, der kræver antikoagulering i sig selv, eller hæmodynamisk relevant klapsygdom, der forventes at kræve kirurgisk indgreb i løbet af undersøgelsen
  2. Alvorligt, invaliderende slagtilfælde inden for de foregående 6 måneder, eller ethvert slagtilfælde inden for de foregående 14 dage
  3. Tilstande forbundet med øget risiko for blødning
  4. Kontraindikation til warfarinbehandling
  5. Reversible årsager til atrieflimren (f.eks. hjertekirurgi, lungeemboli, ubehandlet hyperthyroidisme).
  6. Planlæg at udføre en lungeveneablation eller operation for at helbrede AF
  7. Alvorligt nedsat nyrefunktion (estimeret kreatininclearance <=30 ml/min.)
  8. Aktiv infektiøs endocarditis
  9. Aktiv leversygdom
  10. Kvinder, der er gravide, ammende eller i den fødedygtige alder, som nægter at bruge en medicinsk acceptabel form for prævention under hele undersøgelsen
  11. Anæmi (hæmoglobin <100g/L) eller trombocytopeni (trombocyttal <100 x 109/L)
  12. Patienter, der har udviklet transaminaseforhøjelser ved eksponering for ximelagatran
  13. Patienter, der har modtaget et forsøgslægemiddel inden for de seneste 30 dage eller deltager i et andet lægemiddelstudie
  14. Patienter, der af investigator anses for upålidelige med hensyn til kravene til opfølgning under undersøgelsen og/eller overholdelse af studiets lægemiddeladministration, har en forventet levetid, der er mindre end forsøgets forventede varighed på grund af samtidig sygdom, eller har en tilstand, som efter vurderingen efterforskeren, ville ikke tillade sikker deltagelse i undersøgelsen (f.eks. stofmisbrug, alkoholmisbrug)
  15. Enhver kendt overfølsomhed over for galactose, hvis det anvendte warfarin indeholder galactose.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Dabigatran dosis 2
to gange om dagen
Medicin: Dabigatran dosis 2
to gange om dagen
Aktiv komparator: Warfarin
En gang om dagen
Medicin: warfarin
En gang om dagen
Aktiv komparator: Dabigatran dosis 1
to gange om dagen
Medicin: Dabigatran dosis 1
to gange dagligt

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Årlig hændelsesrate for sammensat endepunkt for slagtilfælde/SEE
Tidsramme: 36 måneder
Tid til første forekomst af slagtilfælde eller systemisk embolisk hændelse. Årlig begivenhedsrate (%) = antal fag med begivenhed / fagår * 100. Emneår = sum(dato for studieafslutning - dato for randomisering + 1) af alle randomiserede forsøgspersoner / 365,25
36 måneder

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Årlig hændelsesrate for sammensat endepunkt af slagtilfælde/SEE/Dødsårsager
Tidsramme: 36 måneder
Tid til første forekomst af slagtilfælde, SEE eller alle forårsage død. Årlig begivenhedsrate (%) = antal fag med begivenhed / fagår * 100. Emneår = sum(dato for studieafslutning - dato for randomisering + 1) af alle randomiserede forsøgspersoner / 365,25
36 måneder
Årlig hændelsesrate: Sammensat af slagtilfælde/SE/PE/MI/vaskulær død
Tidsramme: 36 måneder
Tid til første forekomst af slagtilfælde, systemisk embolisk hændelse, lungeemboli, myokardieinfarkt inklusive stille myokardieinfarkt eller vaskulær død. Årlig begivenhedsrate (%) = antal fag med begivenhed / fagår * 100. Emneår = sum(dato for studieafslutning - dato for randomisering + 1) af alle randomiserede forsøgspersoner / 365,25
36 måneder
Blødningsbegivenheder (større og mindre)
Tidsramme: 36 måneder

Årlig hændelse af blødninger. Årlig begivenhedsrate (%) = antal fag med begivenhed / fagår * 100. Emneår = sum(dato for studieafslutning - dato for randomisering + 1) af alle randomiserede forsøgspersoner / 365,25

Større blødninger er dømt, hvorimod mindre blødninger er efterforsker rapporteret.
36 måneder
Klinisk relevante abnormiteter for intracerebral blødning og anden intrakraniel blødning (ICH)
Tidsramme: 36 måneder
Patienter med klinisk relevante abnormiteter for intracerebral blødning, anden intrakraniel blødning (ICH)
36 måneder
Unormal leverfunktionstest
Tidsramme: 36 måneder
Antal forsøgspersoner med unormal leverfunktionstest (LFT), dvs. ALT/AST >3xULN og total bilirubin >2xULN
36 måneder

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Boehringer Ingelheim

Samarbejdspartnere

Uppsala University
Population Health Research Institute

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Hjælpsomme links

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. december 2005

Primær færdiggørelse (Faktiske)

1. april 2009

Datoer for studieregistrering

Først indsendt

6. december 2005

Først indsendt, der opfyldte QC-kriterier

6. december 2005

Først opslået (Skøn)

7. december 2005

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

17. april 2019

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

8. april 2019

Sidst verificeret

1. april 2014

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 1160.26
  • 2005-003894-26 (EudraCT nummer: EudraCT)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Dabigatran dosis 2

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Hungary

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

3
Abonner